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 ABSTRACT 
 
Eukaryotic cells contain low-molecular-mass metal complexes (LMMMCs), 
defined as having masses between 200 – 10,000 Da, but these so-called labile or 
chelatable metal pools are poorly defined in terms of structures and functions. 
LMMMCs are thought to participate in metal-ion regulation, trafficking, storage and/or 
signaling in cells. These cellular processes are often dysfunctional in metal-associated 
diseases. The objective of these studies was to detect and characterize LMMMCs in 
eukaryotic cells, organelles and tissues. A novel liquid chromatography system in a cold 
inert-atmosphere glove box was interfaced with an in-line inductively coupled plasma 
mass spectrometer, and this LC-ICP-MS system was used to detect LMMMCs in yeast 
cells, mitochondria, and vacuoles as well as in mouse brain and liver cells and 
mitochondria. In each biological system, this separations technique was applied to detect 
numerous LMMMCs. The molecular mass and concentration of such species were 
estimated. 
 In yeast, the previously reported mismetallation of MnSOD2 was examined in 
the mutant strain ∆mtm1. A combination of SEC and AEX chromatography revealed that 
the degree of mismetallation of the SOD2 protein, in which Fe replace Mn in the active 
site, was no greater in ∆mtm1 cells than in WT cells. The mitochondria of such mutant 
cells did exhibit an intense chromatography peak of Mn corresponding to at mass of 
2000 – 3000 Da. Mitochondria from WT cells exhibited a similar species, but at much 
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 lower intensity. This was the only Mn species present, suggesting that it was the used to 
metallate apo-SOD2.   
Mitochondria isolated from WT yeast cells contained 6 Co, 3 Cu, 2 Mn, 5 Fe and 
3 Zn LMMMCs and approximately 6 P- and S- LLM species. Some of the P- and S- 
LMMCs probably arose from compounds like ATP, ADP, etc. Molecular masses of the 
LMM Cu peaks were higher (> 5 kDa) than for the LMM complexes of other transition 
metals. Zinc, Mn, and Fe had multiple species of interest which demonstrate the 
presence and labiality of the metals in pools. 
The same separation system was utilized to examine mice brain LMM extracts 
were found to contain > 30 LMMMCs. Eleven Co, 2 Cu, 5 Mn, 4 Mo, 3 Fe and 2 Zn 
LLM complexes were detected. Most Cu and Zn complexes appeared to be protein-
bound with masses ranging from 4–20 kDa. In these systems, Co was the only metal for 
which the aqueous complex was reproducibly observed. 
A second mouse study used the LC-ICP-MS system to examine the forms of iron 
present in mouse plasma. Chromatograms exhibited ~6 Fe-associated peaks that were 
assigned to ferritin, transferrin, and hemopexin, respectively; the other 3 peaks could not 
be assigned. The LC-ICP-MS experiment demonstrates that numerous Fe-containing 
species coexist with transferrin in healthy WT mouse plasma.  
iii 
 
 DEDICATION 
 
I dedicate this work to my mother and father for all their hard work in nurturing 
my creative and academic development as well as providing endless love. 
 
iv 
 
 ACKNOWLEDGEMENTS 
 
I would like to extend my deepest gratitude to my advisor, Dr. Paul Lindahl. 
From our first conversation my first week of graduate school he has constantly poured 
excitement and energy into my project through its ups and downs. I would like to thank 
him for all his support in my research and graduate school as a whole.  I would also like 
to thank my committee members, Dr. Barondeau, Dr. Vigh, Dr. Hilty, and Dr. Pellois, 
for their guidance and support throughout the course of this research, as well as teaching 
me a great deal in my academic course. 
A great deal goes out to the past Lindahl Lab members Ren, Jessica, Marco, Ivan 
who all nurtured my early research in the lab and took me from a synthetic chemist to a 
biochemist. I am forever grateful for having a great friend, colleague, and mentor, Dr. 
Gregory Holmes-Hampton. I would like to thank Dr. Mrinmoy Chakrabarti for teaching 
me spectroscopy and commiserating with me on many issues during our four years 
together in lab. I would like to also thank Mike, Jinkyu, Nema, and Allison for all the 
great collaborations, conversations, and input. I would like to also thank Dr. Lora 
Lindahl for all she has done for the lab and I, from teaching us mouse anatomy to 
hosting a festive party. 
I would like to thank the wonderful faculty and staff in the chemistry department 
for creating an excellent environment and providing the tools to be productive in both 
the learning and research process. I would like to thank two individuals personally for 
helping me with my graduate student journey. The first is Mr. William Seward in the 
v 
 
 machine shop for teaching me a thing or two about machining, as well as patiently help 
me take some crazy ideas from the back of the napkin to a functional design and part. 
Secondly I’d like to thank Dr. James in the Center for Chemical Characterization for 
teaching me the basics of ICP-MS and having many useful conversations.   
I could not have done graduate school without the support of an amazing group 
of friends from both Texas and Chicago. They provided the perfect mix of scientist and 
nonscientist individuals which allowed for different types of conversation. I love and 
cherish the years I’ve spent with them and wish them the best.  
Finally, thanks to my mother and father for their encouragement throughout my 
life and to my brothers for their patience and love. 
vi 
 
 NOMENCLATURE 
 
AD Alzheimer's Disease 
apo-Sod2p Sod2 protein prior to metal installation 
ASR apo-Sod2p reactive 
ATP Adenosine Triphosphate 
ADP Adenosine Diphosphate 
AMP Adenosine Monophosphate 
BBB blood brain barrier 
CD central doublet 
CIA cytosolic iron sulfur cluster assembly 
CVs column-volumes 
DNP 2,4-dinitrophenylhydrazine 
DTPA diethylenetriamine pentaacetate 
ENDOR electron nuclear double resonance 
EPR electron paramagnetic resonance 
FeASR sought-after Fe species that misincorporates into apo-Sod2p 
FeSod2p inactive form of Sod2p, with Fe bound 
FPLC fast protein liquid chromatography 
FRET Forster Resonance Energy Transfer 
FTS flow-through solution 
GSH glutathione 
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 GSSG glutathione disulfide 
HMM high molecular mass 
HPLC high-performance liquid chromatography 
HS high spin 
ICP-MS inductively coupled plasma mass spectrometry 
IMM intermediate molecular mass 
INT iodonitrotetrazolium 
IP6 inositol hexaphosphate 
ISC iron sulfur cluster 
LA laser ablation  
LC liquid chromatography 
LIP labile iron pool 
LMM low molecular mass 
LMMMC low molecular mass metal complex 
LS low spin 
MF apo-Sod2p maturation factor 
MM molecular mass 
MnASR Mn species that incorporates into apo-Sod2p 
MnSod2p active form of Sod2p, with Mn bound 
MRI magnet resonance imaging 
Mtm1p manganese trafficking factor for mitochondrial SOD2, YGR257C; 
Mol. Wt 40,763 Da 
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 NHHS nonheme high spin 
OD600 optical density at 600 nm 
PD Parkinson's Disease 
PMSF phenylmethanesulfonylfluoride 
ROS reactive oxygen species 
RT room temperature. 
SDH succinate dehydrogenase 
SOD2 superoxide dismutase 2 
TMG trace metal grade 
Ve elution volume 
V0 void volume 
WT wild type 
XAS X-ray absorption spectroscopy 
XRF X-ray fluorescence 
YPAD yeast extract, peptone, adenine hemisulfate, and dextrose 
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CHAPTER I  
INTRODUCTION AND LITERATURE REVIEW 
 
Transition Metal Ions in Biology 
Transition metal ions are essential in biology due to their unique chemical 
properties.(1) They play important roles in catalysis(2), electron transfer processes(3), DNA 
replication and repair(4), gas storage and transport(5). Metals are coordinated to various 
ligands affording prosthetic groups that impact protein structure and function. They also 
play important roles in the metabolism of multicellular organisms including humans.(6) 
Some diseases involve metal ion metabolism dysfunction. Genetic diseases involving 
mutations within the genome and proteome can affect metal ion utilization.(6)  
Metals must be imported continuously from the environment as organisms grow.  
However, metals in the environment are not always present at sufficiently high 
concentration or in forms that are bioavailable.(7) For example, ferric oxides are present 
in high concentrations in the environment, but they are not bioavailable in that form. 
Numerous chemical properties of these compounds impact the ability of cells to uptake 
metals, including hydrolysis, solubility, redox state, ligand exchange rates of metal 
centers, and ligand competition. (7) 
Metal ions become toxic to the cell when they accumulate beyond the 
concentration needed for normal functioning.(8) Different metals may compete for an 
enzyme active site, with occupancy by one metal activating the enzyme and occupancy 
by another causing inactivation.(9, 10) The hyper-accumulation of redox-active transition 
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metals such as copper and iron can generate reactive oxygen species (ROS) such as 
superoxide, hydrogen peroxide and hydroxyl radicals which damage proteins, lipids, and 
nucleic acids.(11, 12)  
Cells have developed mechanisms for responding to the hyper-accumulation of 
metals, and for reducing their toxic effects. These mechanisms include the regulation of 
metal-ion uptake, the sequestration of metals into certain cellular compartments, the 
export of metals from the cell, and the transformation of dangerous metal ion complexes 
into more benign forms.(13)  
 
Metal Related Diseases  
Dysfunctions in metal homeostasis can cause different diseases in humans. All 
essential metals in the cell can be implicated in one or more disease states. Iron-related 
diseases fall under two categories, namely iron deficiency and iron overload.  Anemia is 
the most prevalent iron-related condition, with one-in-six people affected worldwide.(14, 
15) Anemia can be caused by either a dietary lack of iron or by genetic dysfunction. Iron 
overload diseases such as hemochromatosis occur in one of two hundred individuals.(16) 
Iron-overloaded patients accumulate iron in cells and tissues, leading to cirrhosis,(17) 
diabetes,(18) and heart failure(19). At the cellular level, iron accumulation can come from 
genetic or metabolic disorders which create ROS. Other iron-related diseases include 
Sideroblastic anemia(20) and Friedreich’s Ataxia(21). Iron overload contributes to aging 
and neurological diseases such Alzheimer’s and Parkinson’s diseases.(22)  
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The two most prominent copper-specific genetic diseases are Menke’s and 
Wilson’s diseases. These are caused by the mutation of the copper transporters ATP7A 
and ATP7B, respectively.(23) Menke’s disease affects a number of cuproproteins causing 
neurological and growth deficits along with “Kinky” hair.(24) Patients with Wilson’s 
disease exhibit cirrhosis, chronic hepatitis, neurological, and psychiatric problems 
caused by the accumulation of copper in the liver as well as the brain.(24)  Lou Gehrig’s 
disease or Amyotrophic lateral sclerosis (ALS) is a fatal neuron disease which has been 
linked to mutation in the Cu/Zn superoxide dismutase gene.(25, 26) The effects of the 
disease are caused by the aggregation of immature protein which cannot reach full 
maturation because copper cannot be inserted by the chaperone CCS1.(27) Copper bound 
aggregates have been implicated in many neurological and neuromuscular diseases such 
as β-plaques aggregations in Alzheimer’s patients and Lewy bodies in Parkinson’s 
disease. Copper also catalyzes protein cleavage in Huntington’s patients.(28)  
Zinc deficiency can arise from inadequate uptake,(29) genetic disorders,(30) or 
environmental factors(31).  Zinc deficiency affects the immune system’s T and B cells 
along with neutrophils and macrophages.(32) This results in a depressed immune 
response. Also seen in zinc-deficient patients are neurodeficiencies and thymus 
atrophy.(33)  Zinc plays an important role in neurobiology. In contrast to metals like 
copper and iron, zinc prevents the oxidative damage associated with the binding of those 
metals with the amyloid β peptide. Zinc does this by binding the peptide and inducing a 
conformational change which inhibits the binding of these other metals.(34) At elevated 
Zn levels however, there is increased risk of plaques forming through aggregation.(35) 
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Individuals with manganese toxicity exhibit Parkinson-like symptoms which are 
referred to as “manganism”.(36) Manganism patients exhibit lesions in the brain and do 
not respond to dopamine replacement therapy.(37)  Prion proteins play a protective role in 
the brain when it is faced with metal misregulation. Prion proteins protect against 
apoptotic cell death and the formation of ROS by sequestering metal ions.(38) Individuals 
with prion diseases exhibit misfolding of the prion proteins which renders them unable 
to bind the potentially toxic metal ions. When manganese is present in patients with 
prion irregularities there is the possibility of cytotoxicity caused by the generation of 
ROS.    
Cobalt also serves essential roles in human metabolism but can also be toxic 
when present in excess. Cobalt is essential to lipid biosynthesis,(39) and C1 
metabolism.(40) It is found in the B12 cofactor of the enzyme methionine synthase,
(41) 
which is needed for methyl group transfer. Excess cobalt leads to the generation of ROS 
which can mutate DNA.   
Molybdenum is the only metal in the second transitional series which is essential 
to mammals.(42) It plays a vital role as the metal cofactor in molybdenum hydrolases.(43) 
A deficiency of this cofactor in newborns renders them susceptible to seizures and death 
due to their inability to produce the cofactor.(44, 45) Molybdenum also is found in 
xanthine oxidase(46) and aldehyde oxidase(47) in the kidneys, liver, and milk.  
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Labile Metal Pools 
Since metals are essential for metalloproteins, they need to be available to be 
inserted during the protein folding process for nascent proteins. Many proteins 
participate in metal homeostasis and in trafficking metals to recipient apo-proteins.(13) 
Metal homeostasis utilizes import proteins, storage proteins(48), metal chaperones(49), 
metal-sensing proteins,(50) and metal-inserting enzymes(13) to handle metal ions at 
different points in their cellular journey.    
These proteins typically bind metals with high but varying affinities. Typically 
metal ions are passed from one protein to another that has a higher binding affinity for 
the metal. The final recipient metalloprotein typically has the highest binding affinity of 
all the metalloproteins participating in the trafficking process. This makes the pathway 
one directional.(51) The tight binding of metal to metalloenzymes requires that the cell 
contains a supply of metal ions which can be rapidly delivered to newly formed proteins, 
but how this occurs on the molecular level remains unknown. The cell has been 
hypothesized to contain pools of metal ions which are weakly bound to their ligands and 
participate in trafficking.(8) Such pools have been called the labile metal pool(52-54), 
exchangeable pool(55-57), bioavailable pool(58-60), or chelatable metal pool. The 
concentration of the metals in such pools is thought to be regulated by metal-sensing 
proteins which under states of metallic depletion or repletion cause a cellular 
response.(50)  
Labile metal pools are poorly defined in terms of composition, function, and 
structure; there isn’t even a consensus regarding their existence!  Metal ions can 
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probably not roam “free” within the cell (coordinated only to water ligands) due to the 
toxicity of such complexes. “Free” metal ions in the cell would dangerous due to 
possibility of uncontrolled interactions with the proteins, enzymes, and small molecules 
that they encounter.  Thus, metals in labile metal pools maybe composed of low 
molecular mass (LMM) complexes coordinated to non-proteinaceous ligands.   
  The first labile metal pool of interest was discussed by Greenburg and Wintrope 
(61), and subsequently by Jacob (62), as an intermediate or transitory pool between iron in 
the extracellular environment and cellular iron associated with proteins.  The earliest 
experiments carried out by Greenburg and Wintrope used radiolabeled iron supplied to 
cells as a transferrin bound complexes. The radio labeled Fe allowed for pulse chase 
experiments and in combination with subfractionation of the cytosol into high and low 
molecular weight components provided insights by metal tracking. Radioactive Fe was 
taken up by the cell from the environment and trafficked in to the cell where it was 
detected. Over the course of a week radioactive Fe continued to be inserted into nascent 
proteins without the addition of iron to the media. Thus suggesting that the Radioactive 
iron was present in the cell as a form of iron which was waiting to be inserted into 
proteins. Labile metal pools may play a role in metal-associated diseases.  
Understanding these roles will require that the nature of these complexes and their 
location in the cell be identified.  
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Methods for Studying Metal Species in Brains and Cells 
The first attempts to visualize metal species inside cells and in tissue samples 
were carried out using microscopic staining methods. In 1867, Max Perl used potassium 
ferrocynide to stain ferric ions in tissues.(63) Over the course of the next century new 
histochemical staining methods for other metals commonly (e.g. copper) found in 
biological samples were subsequently developed.(64) These methods are still used due to 
their simplicity.” For example, Perl staining for iron was recently used utilized by Huang 
et al.(65) to show the effect of psychological stress on the LMM Fe pools present in 
different regions of the brain.  However, the information obtained from these staining 
methods is limited. Samples must be fixed prior to staining such that time-dependent 
studies are not possible.  
The ability to image metals in cells has progressed significantly in the past few 
decades due to advances in analytical instruments. The utilization of fluorescent 
microscopy and spectroscopy has yielded many insights into metal homeostasis. Three 
main platforms are used in fluorescent spectroscopy to image metals in living cells, 
including those based on small molecule, protein, and hybrid biosensors. Each type of 
biosensor varies in terms of dynamics, binding affinities, and specificity. In small-
molecule biosensors, a fluorescent moiety is attached to a chelating agent. Fluorescence 
is quenched in the unbound state because energy is transferred between the moiety and 
chelating agent.  
Chang and coworkers have developed multiple fluorescent sensors with different 
structures allowing for the detection of both CuI and CuII ions. The fluorescent sensor 
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RSC1 was used to selectively monitor the expansion of endogenous stores of 
exchangeable intracellular CuI triggered by ascorbate stimulation in kidney and brain 
cells.(58) Lippard and coworkers have used the fluorescent sensor ZP3 to monitor the 
synaptic zinc pool in neurons.(66, 67) Using ZP3, Zn was observed to load into vesicles of 
the cerebral cortex and to be subsequently released during synaptic activation.(67) Upon 
binding of the metal ion to the biosensor, fluorescent quenching declines and quantum 
yields increases. The increase in fluorescence is concentration-dependent and therefore 
provides local concentration information. Small molecule probes are highly tunable and 
modular in design, allowing for probe designs with various dynamic concentration 
ranges.  
         The disadvantages of small-molecules platforms become evident when attempts 
are made to introduce such molecules into an intracellular environment in a minimally 
invasive manner. The same membranes which hinder metal uptake block typically 
prevent small-molecule complexes from being imported. This is because the chelating 
agents and fluorescent component are generally charged. Importing such complexes 
often requires minimizing their charge by chemical modification.  This will allow 
translocation of the complex across the membrane. Then, natural occurring enzymes will 
post-translationally modify the complex to an active form. Other methods of introducing 
the complex into the cell include microinjection, microencapsulation, DNA transfection, 
or tethering of the complex to cell-penetrating peptides.   
Protein-based sensors are also used to image metals in cells. In these platforms 
fluorescent proteins are tethered to metal binding domains which are either naturally 
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occurring or custom engineered. The protein-based platforms can be singular or multi-
protein in nature. In single protein platforms metal binding induces a conformational 
change which perturbs the fluorescent intensity or the wavelength. Multiprotein 
platforms rely heavily on Forster Resonance Energy Transfer (FRET) in which two 
fluorescent proteins are bridged by a metal binding domain. The metal ion binds in the 
domain and induces a change in the complex either in the orientation or distance 
between the proteins causing a change in the rate of energy transfer between the donor 
and acceptor proteins. Through monitoring the fluorescence of the donor and acceptor 
quantitative metal concentrations can be determined.  Palmer and coworkers have 
developed organelle-specific protein based FRET sensors that detect zinc in Hela cells at 
low pM concentrations.(68, 69) Three genetically encoded FRET-based sensors have been 
developed for visualizing cellular CuI offering a range of affinities and the ability to 
quantify bioavailable copper in yeast at the range of 10-17 to 10-21 M.(70)   
The use of protein-based platforms is inherently a dual-edge sword. Proteins can 
easily be genetically encoded in the cells or introduced using viruses. The expression of 
the sequence which encodes the protein-based sensor can be placed under an inducible 
promoter. One drawback is that expressing a nonnative protein might perturb the metal 
homeostasis in the cell.  
Hybrid systems consist of a fluorescent protein fused to small-molecule sensors. 
Protein-based sensors allow for the genetic encoding needed to target a specific type of 
cell or a specific cellular organelle.  Small-molecule sensors can be tuned to have 
specific properties like excitation wavelength for detection and a detectable 
9 
 
  
concentration range from pM to µM concentrations. These hybrid systems allow genetic 
specificity to be merged to spectral diversity and a large dynamic range. 
 
Magnetic Resonance Imaging 
MRI is a valuable technique for studying metal ions in samples that are opaque. 
MRI provides 3D imaging of metal ion distributions with high spatial resolution. Two 
types of MRI signals can be observed, each due to different phenomena. The first type of 
signal arises from the modulation of the relaxation properties of water associated 
protons. The second type of signal arises when contrast agents interact with metal ions.  
Metals in the brain and other organs have been studied by MRI techniques 
without contrast agents. Chen and coworkers utilized MRI to look at changes in brain 
iron distribution after introventricular hemorrhage.(71) MRI has also been used to 
examine plaques present in the brains of Alzheimer’s and Parkinson’s patients.  Second-
generation contrast agents allow different metals to be selectively detected. Many 
examples of metal specific MRI contrast agents based on Gadolinium sensor have been 
developed. Meade and coworkers have designed Zn activated contrast agents which have 
high selectivity for ZnII.(72) Other MRI sensors have been developed in the Chang Lab 
.(73-77) This group has designed sensors for both CuII and CuIII labile metals whose 
binding affinities were measured to  have Kd values spanning three orders of magnitude 
from 0.037 to 32 pM.(76)  The sensors are highly specific for copper.(78)  Their copper 
MRI contrast agents have been used to study cell lines which exhibit the Menke’s 
disease phenotype.(79) Lippard’s laboratory developed MnIII based porphyrin contrast 
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agents which have a MRI relaxivity modulated by ZnII.(80) When introduced into 
mammalian cell lines, the MRI probe exhibited a concentration-dependent response and 
a rather high degree of metal selectivity. 
  
X-ray Fluorescence Spectroscopy 
Another analytical imaging technique is x-ray fluorescence (XRF). For each 
element, XRF gives information on its concentration, oxidation state and average 
coordination environment. In XRF, samples are bombarded with X-rays, causing the 
excited core shell electrons of the atom to become excited. These electrons subsequently 
relax with the emission of photons. The emitted photon energy is specific for each 
element, allowing different elements within a sample to be distinguished. Nichol et al,(81-
83) used fast-scanning XRF analysis to map the distribution of metals in various regions 
of the brain. Their results confirm that the substania nigra region of the brain contains a 
significant amount of iron.(84) They also suggest that regions containing pools of iron 
have low zinc concentrations. These researchers observed abnormalities in the metal 
distributions in brains from individuals with Parkinson’s and Amyotrophic Lateral 
Sclerosis (ALS) diseases.  Rabionet and Ide-ektessabi suggest that oxidative stress is a 
critical factor in neurodegenerative disease development or progression.(85) This is based 
on XRF data which shows an imbalance in Zn and Cu, as well as in the ferrous and ferric 
redox pair, within diseased brains.(85) These authors suspect that such imbalances are 
associated with an increase in oxidative stress. X-ray fluorescence is an extremely 
sensitive technique, with detection limits in the 10-100 µg/L range. By focusing the x-
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ray beam and optimizing sample preparation, spatial resolution of 100 nm is possible. 
While XRF spectroscopy is a highly effective imaging tool, the limited availability of 
synchrotron sources and the need to chemically prepare a sample for analysis prevents it 
from becoming a mainstream technique. 
 
Laser Ablation Inductively Coupled Plasma Mass Spectrometry 
Another technique for imaging cells and tissues is Laser Ablation Inductively 
Coupled Plasma Mass Spectrometry (LA-ICP-MS). This technique is used to measure 
metal ion concentrations in solid samples. A laser beam is focused on the sample causing 
a micrometer diameter spot to ablate. The ablated sample enters the ICP using a stream 
of argon carrier gas. In the plasma, the sample is vaporized, atomized, and ionized. The 
ionized material is separated by mass-to-charge ratio and detected by the mass 
spectrometer.  LA-ICP-MS has been used to study strokes and aging in mice brains. 
Becker et al.(86) induced thrombosis in mice similar to that expected in traumatic brain 
injury. Using LA-ICP-MS, they discovered a large concentration of iron at the site of the 
thrombosis. Becker et al. also found an increase in copper and zinc around the injury. 
They suggested that the copper and zinc became incorporated in Cu, Zn superoxide 
dismutase. This enzyme might be needed to scavenge ROS generated from the excess Fe 
which participated in Fenton chemistry.   LA-ICP-MS has been utilized for a vast 
number of sample types including Alzheimer plaques,(87) brain stems and cerebellum 
samples,(88, 89) and spinal cords(90). LA-ICP-MS has also been coupled to laser 
microdissection to better resolve brain regions.(91, 92)  
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LA-ICP-MS is a sensitive spectrometric technique useful in the bioimaging of 
trace metals sections of biological tissues. One disadvantage is its limited resolution. In 
current instruments the resolution is on the order of 5-150µm, nanometer resolution 
maybe possible in the near future. Another disadvantage is that the instrument must be 
calibrated using solid standards in matrixes similar to that of the sample, which is 
difficult to perform accurately. The biggest disadvantage in using LA-ICP-MS comes 
from its inability to reveal any speciation of compounds. 
 
Problems with Metal Detection Methods in Cells 
The methods discussed typically provide large amounts of spatially resolved data 
regarding the localization of metals and distributions of different metals as a whole 
within tissues and cells. The fluorescent-chelator approach has yielded critical 
information regarding the real-time trafficking of metals in cells. This approach affords 
high resolution images that are essentially selective for a given metal.  The biggest 
question for scientist studying metal homeostasis is wither metals are trafficked solely 
by proteins or are there low molecular mass metal species which play a role in 
trafficking. Chelator based studies cannot directly answer the question due to their 
nondiscriminating nature. A chelator may be selective for a specific metal but not for a 
particular metal-bound species in the cell.  This makes it extremely difficult to determine 
where the metal being detected comes from or how many different protein or LMM 
species are contributing to the fluorescent response. Pools of metals (either 
proteinaceous or non proteinaceous) used in trafficking should be composed of metals 
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with preferred redox states and coordination environments which would allow them to 
be useful but not toxic to the cell. However there have been no LMM complexes that 
have been isolated and characterized in the literature for eukaryotic systems. Knowledge 
of the structure and function of the proteins or LMM pools might eventually aid in 
treating metal related diseases by understanding ways to control metals species in cells.   
 
Liquid Chromatography and Inductively Coupled Plasma Mass Spectrometry  
The most direct method to separate and characterize metal containing complexes 
is to use liquid chromatography interfaced with inductively coupled mass spectrometry 
(LC-ICP-MS). The method draws on the strengths of two analytical techniques. LC is a 
very versatile technique with an extended range of possible separation mechanisms 
which utilize different combinations of stationary and mobile phases.  This allows one to 
separate complexes with a high degree of resolution. The interfacing of LC to the ICP-
MS allows for sensitive and selective detection of metals and nonmetals in a variety of 
sample matrices.  
The use of traditional LC-ICP-MS methods comes with some complications. The 
mobile phase of the LC separation typically contains a buffer which stabilizes some 
biomolecules. However, such buffers often alter the equilibria of the target species, yield 
unnatural complexes, or contribute metal contaminates into the sample. The same types 
of issues arise with many stationary phases which suffer from chemical absorption, 
contamination, or alteration of the analyte during the course of the separation.  
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In 1989, prior to the interfacing of LC to ICP-MS, Pollack and Weaver utilized 
anion exchange chromatography to isolate Fe-AMP and Fe-ATP from guinea pig 
reticulocytes.(93) The separation was carried out under aerobic conditions using buffers 
with extreme pHs. Aerobic isolation is problematic because some labile metal 
complexes are susceptible to oxidation by molecular oxygen. In order to alleviate 
artifacts caused by the presence of molecular oxygen all sample preparation and 
manipulations, along with the separation, itself should be carried out in an anaerobic 
glovebox.  The authors suggested that their results were potentially artifactual.  The acid 
pH of the separation buffer used to prepare the sample causes the hemolytic release of a 
high concentration of iron from transferrin during lysis. This iron is free to react with 
ATP and ADP which is found at high concentrations in reticulocytes. The Fe-ATP, Fe-
ADP, and Fe-AMP detected could be an artifact of the protocol.  
The utilization of size exclusion chromatography (SEC) hyphenated to ICP-MS 
to detect metal containing protein separated by molecular weight is not a new technique 
for analytical chemists. SEC-ICP-MS has been used to study various trace metals in 
samples with a wide range of pathologies and disease states including but not limited to 
rat serum(94), cancerous thyroid tissues(95), mouse neurons(96), as well as various blood 
products(97).  
While useful information has been obtained from the previous studies a majority 
of these studies were focused on metal-containing proteins such as transferrin, copper 
zinc superoxide dismutase, or ferritin. Experiments which focused on small metal 
complexes required the addition of nonphysiological concentrations of metals to 
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measure detectible signals.  The experiments were also carried out aerobically and at 
ambient temperature. From an inorganic chemistry prospective this could be 
problematic. The aerobic handling of metal complexes (iron in particular) offers the 
possibility of oxidation and thus most likely changes in the coordination environment of 
the complexes.  Executing the experiment at ambient temperature increases the 
possibility of ligand exchange.  Thus that complexes detected could be the result of 
unnatural ligand exchange over the time course of the experiment.   
 A final concern is the lack of documented reproducibility in published 
chromatograms. Biochemical research is in itself susceptible to variations of varying 
degrees, therefore reproducibility must be demonstrated. Previous publications do not 
typically show data or chromatograms from more than one experimental run. The reader 
is expected to accept the results with little to no demonstrated reproducibility. 
 
Objectives 
The lindahl lab is focused on iron trafficking in cell biology. The literature has 
made cases for metal trafficking involving solely protein bound iron chaperones, as well 
as cases for iron trafficking using labile metal pools. Previous studies of iron pools have 
not yielded precise chemical information on these pools, such that the composition and 
functions of such pools remains uncertain. The objective of my research was to detect 
and isolate the iron isolated which constitute the labile pools in different biological 
systems.  One major problem in isolating these iron species is that Fe2+ readily oxidizes 
in air to form Fe3+. We suspect that in previous studies of labile iron pools using LC, the 
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iron in the sample became oxidized and precipitated on the column or was eluted as a 
non-native species.  In order to detect and isolate the iron containing species LC-ICP-
MS was selected. The LC was placed inside an anaerobic glovebox to avoid oxidation. 
To decrease the rate of ligand exchange the system has been refrigerated to 5oC. These 
two approaches in combination with LC-ICP-MS have not been previously reported in 
the literature. 
In 2009, Culotta hypothesized the existence of a large “bioavailable” pool of iron 
in the mitochondria of Δmtm1 yeast.(98) She proposed that this “bioavailable” iron pool 
would interact with SOD2 protein causing mismetallation and inactivation of the 
enzyme. We suspected that this “bioavailable” iron would be in the high spin FeII form 
and could be the long sought-after mitochondrial labile iron pool. In chapter 3 of this 
dissertation we sought to characterize the “bioavailable” iron in the mitochondria of 
Δmtm1 using a combination of biophysical and bioanalytical approaches.  
After studying iron and manganese in the previous chapter we moved on to study 
all LMM species in yeast mitochondria while addressing all biologically interesting 
transition metals along with sulfur and phosphorus. Little is known about these pools 
and in chapter 4 we discuss the knowledge gained through our studies.   
The brain is thought to be susceptible to metal misregulation.(99) Previous 
research has shown elevated levels of ROS in many neurological disease states. The 
misregulation of metals and its subsequent generation of ROS make it an important area 
to study. Numerous groups have studied the localized concentrations of metals in the 
brain and the spectroscopic properties of metals in the brain.(89, 100-103) The problem is 
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still the lack of knowledge about the structure of these LMM metal complexes which 
make up the pools. In Chapter 5, we will utilized LC-ICP-MS to determine the presence 
of LMM metal species in the brain and provided the groundwork for their future in depth 
studies.  
A second mouse experiment is carried out in chapter 6. We use LC-ICP-MS to 
examine the forms of iron present in the plasma of mice. Along with determining the 
forms of iron we investigated the  iron uptake variety of organs and in the plasma using 
stable isotope analysis. Overall, the results presented in this dissertation include the 
detection of over 50 previously unreported LMM metals complexes in biological 
systems, the detection of 6 different iron compounds in mouse plasma, and insight into 
what happens to iron in the brain during aging. These advances constitute a solid 
foundation for future LMM metal studies in the Lindahl Lab.   
.  
18 
 
 CHAPTER II  
MATERIALS AND METHODS* 
 
 The primary methods used in these studies are liquid chromatography (LC) and 
inductively coupled plasma – mass spectrometry (ICP-MS). The LC served as a method 
of biochemical separation and the ICP-MS served a dual role as an element specific 
detector for the LC, as well as a highly sensitive method for determining metal 
concentrations in the various systems. 
 
Inductively Coupled Plasma –Mass Spectroscopy (ICP-MS) 
ICP-MS is an analytical technique developed in mid-1980’s by Alan Gray and 
Sam Houk as a means of detecting and measuring all metallic elements from lithium to 
uranium with detection limits around 100ppb with modest level of error. The capability 
that separates ICP-MS from its predecessors, atomic absorption based techniques, is the 
ability to gain isotopic information about the samples, which is why it’s a mass 
spectrometry based instrument.   
While ICP-MS instrument designs have advanced over the past half a century all 
ICP-MS follow a basic design with four main components: sample introduction, argon 
plasma torch, ion extraction/focusing, mass separation and detection. All four 
components will be briefly discussed. 
Solution based samples are introduced into the plasma using a combination of 
Micromist nebulizer, Peltier cooled spray chamber and a quartz torch. The Micromist 
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 *Reprinted with permission from “Changing iron content of the mouse brain during development” 
by Gregory Holmes-Hampton, Mrinmoy Chakrabarti, Allison Cockrell, Sean McCormick, Louise Abbott, 
Lora Lindahl, and Paul Lindahl, Metallomics 4, 761-770. Copyright 2012 by The Royal Society of Chemistry.                                                  
 nebulizer aerosolizes the solution in a argon gas stream creating droplets of the solution 
of various sizes which are sprayed into the spray chamber. The spray chamber is cooled 
to 2o C using a Peltier cooler. The spray chamber removes the larger droplets though a 
complex cooled flow path and allows only the smallest uniform droplets to pass reducing 
the amount of solvent vapor entering the torch and the plasma. The droplets then pass 
through to the torch. The torch is a piece of quartz consisting of three concentric tubes 
which are positioned inside a copper coil which is connects to a radiofrequency (RF) 
generator.  
A tesla spark ignites the plasma at the end of the torch and the plasma is 
maintained using oscillating magnetic fields created from the RF flow in the copper 
coils. The tesla spark causes electrons to be stripped off the argon atoms, resulting in 
argon ions. The argon ions interact with the oscillating magnetic and electric fields 
causing intermolecular collisions to occur amongst argon atoms, thus resulting in an 
argon discharge, or more commonly caused plasma formation. When a sample is 
introduced in to the plasma it is rapidly desolvated and atomized into the gas phase. 
Once in the gas phase the atoms are ionized to single charged ions. It is these ions which 
will be analyzed by the mass spectrometer. 
Ions entering the mass spectrometer do so through an interface region of the ICP-
MS consisting of interface cones under pressure of 1-2 torr. The interface cones are 
referred to as the sampling and skimmer cones. The sampling cone contains a 1mm ID 
orifice in a platinum cone, while the skimmer cone contains a 0.4mm ID orifice. The 
decrease in pressure from atmospheric to 1-2 torr causes the ion beam to undergo 
20 
 
 supersonic expansion resulting in a ion beam with a steady composition. This allows for 
a representative sampling of the plasma at the skimmer cone region.    
The ions focused through the skimmer cones then enter the low pressure region 
of the instrument, less than 1x 10-5 torr, where they are focused through a series of 
electrostatic plates, known as ion lenses. The ion lenses guide and focus the ion beam, 
while also separating the ions from photons and neutrals created within the plasma. This 
decreases the background signals created through random collisions with the detector.  
The focused ion beam is introduced into the collision/reaction cell, where gases such as 
Hydrogen or Helium can be added to remove spectral interferences. The gases in the 
reaction cell can remove polyatomic interferences using one of two methods. The first is 
reaction mode (Hydrogen Mode). In reaction mode polyatomic interferences are 
removed or minimized through chemical reaction with the gas. The second mode is 
collision mode (Helium Mode). In collision mode, the gas (helium) collides with the 
larger polyatomic interfering ion resulting in the loss of kinetic energy. The increased 
size of polyatomics ions over analytes results in an increase number of collisions for the 
polyatomic ions. The increased number of collisions causes a greater loss in kinetic 
energy allowing for energy discrimination to be used to separate analyte from 
polyatomic interferences. In both cases these polyatomic interferences are then removed 
by an octopole. 
Upon passing through the ion lens as well as the collision/reaction cell the ions 
finally make it to the mass analyzer. In the case of the Agilent system a quadruple is 
used to separate ions based on their mass to charge ratio (m/z). A quadropole is a mass 
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 filter composed of two pairs of parallel cylindrical rods positioned on the axis of the ion 
beam. A dynamic hyperbolic electric field (DHEF) is created using a combination of AC 
and DC voltages. The 2 pairs of rods have the same AC voltage applied out phase 
between the two pairs. The DC voltage is made positive for one pair and negative on the 
other.  The DHEF filters ion out which are above or below the mass desired by causing 
the ion to have an unstable trajectory and be lost for the ion beam. Different masses can 
be selected for by varying the AC and DC fields but keeping the ratio on one to another 
constant. The ability to rapidly change voltages allows for the nearly simultaneous 
detection of multiple elements. The ions of interest which make it through the 
quadropole are then ready for detection. ICP-MS utilizes an electron multiplier to 
generate detectable signal pulse from the impact of a single ion. The positive ion reaches 
the detector and is deflected by the first dynode. The impact causes the release of several 
free electrons which bounce from dynode to dynode creating a cascade of electrons 
repelled from the previous dynodes to an ECD which measures the ion count.  
 The use of ICP-MS comes with both advantages and limitiations. ICP-MS is a 
“hard” ionization technique which allows for the complete dissociation of molecule to 
atoms and atomic ions allowing for elemental detection even in complex matrices.  ICP-
MS has detection limits 100x better than that of optical based emission techniques and 
can measure the full range of metals within a 2-3 min window. It has a large linear 
dynamic range over a concentration range of 109 provides elemental isotope information 
which can be used to correct for polyatomic interferences in the plasma or carry out 
experiments using single isotope incorporation or spiking.  The robustness and advances 
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 in ICP-MS systems allow for customization of techniques for sample introduction. ICP-
MS does suffer from some limitations including high instrument cost both initially and 
operationally. The sensitivity of ICP-MS requires those who operate and prepare 
samples to be trained in trace metal techniques and to operate in a clean environment or 
risk misleading data.   
 
Liquid Chromatography (LC) 
 LC is widely used analytical technique used to separate components from 
a mixture. In liquid chromatography the separation is carried out by applying the sample 
to a column containing a solid stationary phase while a liquid mobile phase is pumped 
through the column continuously. A physical or chemical interaction of the analytes with 
the stationary phases causes them to separate. The two chromatographic methods used in 
the  following work are size exclusion and ion exchange chromatography. 
Size exclusion chromatography (SEC) is a separation technique which utilizes 
the molecular sieve effect to separate molecules based mostly on their size but also 
partially on the molecular shape. The theory is a small analyte will be retained longer in 
a pore on the stationary phase due to its ability to penetrated deeper into pore and 
explore a greater amount of the interparticular volume.  Larger analytes lack the ability 
to penetrate the well-defined pores and thus take less time to be eluted from the column.  
Ion exchange Chromatography (IEC) is separation technique which involves the 
interaction of a negatively charged analyte with a cationic stationary phase or a 
positively charged analyte on an anionic stationary phase. The stationary phase is either 
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 a polymeric or silica bead which is functionalized with typically a quaternary amine or a 
sulfonate type group.  The analyte is retained by the stationary phase if the charge of the 
complex is opposite that of the stationary phase and the relative strength of the retention 
is dependent on the electrostatic interactions present. The analyte is eluted off the 
column using an aqueous solution and a gradient of increasing salt concentration. The 
salt in the elution buffer displaces the analyte from the stationary phase as long as it has 
higher ionic strength.    
 
 Hyphenation of LC- ICP- MS 
HPLC-ICP-MS is the most popular of all hyphenation techniques used in 
elemental speciation because it offers unparallel opportunities. HPLC-ICP-MS offers 
scientist the variety of separation mechanisms afforded by HPLC, a highly sensitive and 
robust element specific detection methods, and a straightforward interface between the 
LC and ICP. 
As mentioned earlier the application of LC with ICP affords the users a variety of 
separation methods to applies to their sample. These separation methods each have 
different mobile phases most containing a gradient of either salt or organic solvent. The 
main issue with using linear gradients of salts for the elution of small metal complexes 
comes when the mobile phase often exceeds 0.1M salt concentration. This results in 
instability and decreased sensitivity of the ICP-MS because of the clogging of the 
nebulizer and sampler and skimmer cones with crystallized salt. When organic solvent 
gradients are utilized the same plasma instability and loss of sensitivity can be observed. 
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 This is due to the large amount of carbon which can be deposited in the sample path and 
on the ion optics in the system from the burning of the organic phase. The advances in 
capillary and nano flow LC systems have made LC-ICP-MS even more attractive 
because the decreased amount of matrix sprayed into the ICP-MS affects the plasma 
less. 
The interface allows for the connection of the post column eluent flow to be 
directed directly in to the ICP-MS with simple connections.  The flow rate of current LC 
systems can be accommodating by the ICP-MS using the standard spray chambers and 
nebulizers. The online coupling of Liquid chromatography methods and ICP-MS has 
successfully utilized ICP-MS as an element specific detector to monitor the 
chromatographic separation. ICP-MS are preferred to other atomic spectroscopy 
techniques due to its high sensitivity ( pg mL-1 ),  wide dynamic range, multielement 
capabilities and its ability to monitor multiple isotopes. In order to minimize 
contamination, obtain better analytical repetition, and decrease analysis time the online 
hyphenation of the LC to the ICP is preferred relative to the offline system.   
 
 
 
 
Chemicals and Standards 
The water used was house-distilled, deionized using ion-exchange columns 
(Thermo Scientific 09-034-3), and then distilled again using a sub-boiling still (Savillex 
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 DST-1000). Cytochrome c (Saccharomyces cerevisiae), aprotinin (bovine lung), ATP, 
ADP, AMP, and cyanocobalamin were from Fisher Scientific (Pittsburgh, PA, USA). 
Inositol hexaphosphate (IP6), oxidized and reduced glutathione, sodium molybdate, and 
sodium phosphate were from Sigma Aldrich (St. Louis, Mo, USA). The molybdopterin 
cofactor was isolated as described(43) from xanthine oxidase. The sample buffer was 20 
mM Tris (Fisher) pH 7.4. 
 
Yeast Strains and Media 
The Δmtm1 mutant strain used in Chapter 3 was derived from WT strain W303 
(MATα, ura3-1, ade2-1, trp1-1, his3-11,15, leu2-3,112). Gal-YAH1 is a derivative of 
W303 containing a galactose-inducible YAH1 promoter.(104) W303 and Δmtm1 cells were 
grown on standard rich medium with 2% (w/v) glucose and 40 mg L−1 adenine 
hemisulfate dihydrate (YPAD) agar plates for 3–4 days. Gal-YAH1 cells were grown on 
standard rich medium with 2% (w/v) galactose and 40 mg L−1 adenine sulfate agar plates 
for 3–4 days. Generally a colony taken from the agar plate was inoculated in Fe-deficient 
minimal medium containing 2% (w/v) glucose, supplemented with 100 mg L−1 leucine, 
40 mg L−1 adenine hemisulfate dihydrate, 20 mg L−1 uracil, 20 mg L−1 histidine, 50 mg 
L−1 tryptophan, and 1 μM copper sulfate. Either natural-abundance Fe-citrate or 57Fe-
citrate was added to minimal medium at 20 μM final concentration. For manganese 
supplementation, 200 μM MnCl2 was added to minimal medium (the [Mn] in 
unsupplemented minimal medium was 2 μM). 
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 Yeast defined as wild type in chapter 4 is of the BY4741 (MATα, ura3Δ0, 
leu2Δ0, met15Δ0, his3Δ1) strain. BY4741 cells were grown on standard yeast peptone 
medium with 2% glucose (YPD) agar plates for 3-4 days. Colonies were selected from  
agar plates and inoculated in to iron free minimal media containing 2% (w/v) glucose, 
supplemented with 100 mg/L Leucine, 40 mg/L adenine hemisulfate dihydrate, 20mg/L 
uracil, 20mg/L histidine, 20 mg/L  methionine, and 50 mg/L tryptophan.  Metals were 
added to the media in the form of copper sulfate and 57Fe citrate to achieve final 
concentrations of 1µM and 10µM, respectively. For metal supplementation experiments, 
Zn acetate or MnCl2 were added in addition to the copper sulfate and iron citrate. 
 
Cell Growth and Mitochondria Isolation 
Cell stocks were prepared in 15% glycerol and frozen at −80 °C. As needed, 
frozen cells were scraped with a sterile wooded stick, and spread onto an agar plate. 
Single colonies were used to inoculate 50 mL of medium. Once grown, the cultures were 
used to inoculate 1 L of minimal medium (YPAD medium for Δmtm1 cells). When 
OD600 reached 1, cultures were transferred into 24 L of minimal medium at 30 °C in a 
stirred glass fermenter. Solutions were purged with O2 or Ar ( 1 L min
-1) to achieve 
aerobic and anaerobic growth conditions, respectively. Cells were harvested at OD600 = 
1.0 ± 0.1. 
Mitochondria were isolated in a refrigerated Ar-atmosphere glovebox as 
described.(105) Solutions used under anaerobic conditions were degassed on a Schlenk 
line and then brought into the box. Isolated mitochondria were packed into EPR tubes or 
27 
 
 Mössbauer cups by spinning either at 10 000 × g for 1 hr or at 18 000 × g for 30 min in 
an ultracentrifuge with a swinging-bucket rotor. Samples were frozen in liquid N2 for 
further analysis.  
 
SOD Activity Assays 
Six batches each of WT and Δmtm1 cells were grown on 200 mL of minimal 
medium and harvested at OD600 between 0.6–1.8, matched to within 0.2 absorbance 
units for each pair of batches. Cells were harvested and lysed by glass-bead agitation. 
For anaerobic growth, the medium was purged with Ar, and cells were harvested in the 
glovebox and processed under an Ar atmosphere. Cells were resuspended in lysis buffer 
containing 10 mM sodium phosphate (pH 7.8), 0.1% (v/v) Triton X-100, 5 mM EDTA, 5 
mM EGTA, and 50 mM NaCl. An equivalent volume of 0.5 mm glass beads (Biospec 
Inc.), 1 mM PMSF and 1% (v/v) protease inhibitor cocktail (P8340, Sigma) were added 
to cell suspensions. Cells were agitated by vortex action for 1 min and cooled on ice for 
≥1 min; this procedure was repeated 6 more times. Lysate was clarified by centrifugation 
at 16 000 × g for 10 min at 4 °C. The supernatant was passed through a 0.45 μm 
centrifuge tube filter (Millipore), and the filtrate was stored at 4 °C or in the glovebox. 
The SOD activity gel assay was performed using 60 μg of whole-cell protein was 
loaded onto 12% Tris-HCl gels (Bio-Rad). Native gel electrophoresis was performed at 4 
°C. The gel was soaked in a stain containing 50 mM potassium phosphate (pH 8.2), 0.16 
mM nitro blue tetrazolium (NBT), 0.27 mM riboflavin, 1mM sodium cyanide, 6.7mM 
TEMED (N,N,N′,N′-tetramethylethylenediamine), and was incubated in the dark for 1 h 
28 
 
 at 4 °C. The yellowish gel was exposed to light from a 40 W white bulb for 10-15 min to 
develop a blue background with colorless SOD bands. Gels were imaged by a Fujifilm 
LAS-4000 mini imaging system. The density of each band corresponding to SOD2 
activity was quantified by using NIH ImageJ software and normalized to aerobically 
grown W303 activity. 
Sod2p solution activity was measured by monitoring the reduction of NBT by a 
photochemical flux of O2
−. The reaction  mixture was prepared in 330 μL of 50 mM 
potassium phosphate buffer at pH 7.8 containing 0.1 mM EDTA, by adding 10 μL of 90 
mM NaCN, 33 μL of 1 mM NBT, 50 μL of 0.1 M methionine, and 10 μL of 0.16 mM 
riboflavin. Enzyme and water were added to a final volume of 1.0 mL. In the absence of 
enzyme, background formation of blue formazan was monitored at 550 nm after every 
10 s exposure to a 40 W white light bulb at the intensity required for the absorbance to 
increase at a rate of  0.05 min−1. One unit of SOD activity was defined by the amount of 
protein required to inhibit formazan formation by 50%. 
 
Western Blots 
Whole cell lysates and purified mitochondria were analyzed by Western blot. 
Lysate (60 μg) and mitochondrial (20 μg) proteins were resolved by 12% SDS-PAGE 
and transferred onto polyvinylidene fluoride membranes (Bio-Rad). Membranes were 
blocked with 1% casein and incubated with an antibody against Sod2p. Blot densities on 
membranes were quantified as above. 
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 Yeast Protein and Iron Content Analysis 
Whole cell lysate and mitochondrial protein concentrations were measured by the 
BCA protein assay kit (Pierce). Mitochondrial and whole cell metal concentrations were 
measured by ICP-MS (Agilent, Inc., Tokyo, Japan; model 7700×). Packed mitochondria 
and whole cells were diluted 2-fold with water. Then 50, 75 and 100 μL of the resulting 
suspensions were dissolved overnight in 200 μL of 30% trace-metal grade HNO3 and 
100 μL of 35% trace-metal grade HCl (Fisher Scientific). Reported protein 
concentrations in mitochondria and whole cells were acquired from packed mitochondria 
and cells, and adjusted using previously reported packing efficiencies of 0.70 for whole 
cells and 0.77 for mitochondria.  
 
Chapter 3  Separation Experiments 
In the first group of experiments, isolated mitochondria were resuspended in 10 
mM HEPES (pH 7.2) containing 1 mM PMSF, and sonicated 3 times for 30 s each with 
a Branson 450 sonifier at a 60% duty load using a two-step microtip. The suspension 
was pelleted at 18 000 × g for 30 min and the soluble mitochondrial layer was collected. 
For the first LC-ICP-MS experiment of this group, the pellet was resuspended in buffer, 
and the second soluble fraction was collected after centrifugation and combined with the 
first soluble fraction. For the second and third experiments of this group, the second 
soluble fraction was not combined. Extracts (2 mL injections) were passed through a 
Superdex 200 pg 16 × 600 mm column (GE Life Science) equilibrated in 25 mM Tris-
HCl pH 7.7. Buffer was prepared in double-distilled deionized trace-metal-free water. 
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 The elution flow rate was 0.75 mL min−1, controlled by an ÄKTA (GE Healthcare Life 
Science, New Jersey, USA) FPLC. The entire system was housed in a refrigerated (7 °C) 
Ar-atmosphere glovebox (Mbraun USA Inc., Stratham, NH) with O2 < 3 ppm as 
monitored by a Teledyne Model 310 analyzer. 
The second group of LC studies involved size-exclusion chromatography of 
LMM species. Isolated mitochondria were solubilized with 1% (w/v, final concentration) 
sodium deoxycholate in 100 mM Tris at pH 7.4, and the supernatants were filtered 
through a 10 kDa cut-off membrane using an Amicon stirred concentrator. The filtrates 
were applied (0.5 mL injections) to two Superdex Peptide 10 × 300 mm columns (GE 
Life Science) connected in series and equilibrated with 25 mM Tris-HCl pH 7.7, driven 
by a Bio-Inert HPLC (Agilent, Tokyo, Japan). The elution flow rate was 0.375 mL 
min−1. The entire system was located within a refrigerated glovebox. 
The third group of LC studies involved anion-exchange chromatography (Mono 
Q 4.6/100 PE GE Healthcare; 1.7 mL column volume, CV) of mitochondrial extracts. 
Extracts were prepared as described above for HMM size-exclusion studies involving 
sonication, except that the sonication buffer was 20 mM Tris pH 7.2. Buffer A (20 mM 
Tris pH 7.2) and Buffer B (same as A but with 1 M NaCl) were used to generate the 
elution buffer gradient. The column was washed with 8 CVs of Buffer A. Proteins were 
eluted using 25 CVs of a 0 → 1 M NaCl linear gradient, followed by 8 CVs of Buffer B. 
For the second study, 5 CVs of Buffer A were passed through the loaded column 
followed by 3 CVs of 71% Buffer A mixed with 29% Buffer C (20 mM Tris pH 7.2 plus 
0.35 M NaCl). This was followed by 25 CVs of a linear gradient (29% → 100% Buffer 
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 C) and finally by 5 CVs of Buffer C. The elution flow rate was 1 mL min−1. The Bio-
inert HPLC was used for these studies. 
Aqueous FeIII and many other FeIII complexes are insoluble at neutral pH and tend 
to adhere to column media. FeII is easily oxidized to FeIII in air, and even under 
essentially anaerobic conditions, Fe accumulated on our LC columns. Thus, after each 
use, the size-exclusion columns were cleaned by passing 5 CVs of a chelator cocktail 
containing 10 μM each of EGTA, EDTA, diethylenetriamine pentaacetate, and 2,2-
bipyridine followed by 10 CVs of elution buffer. (WARNING: Early attempts to use 10 
mM of the same chelator cocktail seemed to damage the column media.) This was 
followed by 15 CVs of elution buffer. The Mono Q column was cleaned by passing 15 
CVs of 20 mM Tris plus 1 M NaCl, then 15 CVs of 10 μM EGTA and EDTA, followed 
by 10 CVs of 20 mM Tris (without NaCl). 
The ICP-MS was used in collision cell mode (He: 4.3 mL min−1) with platinum 
cones. The instrument was optimized daily using manufacturer's tuning solution. The 
sample was introduced through a standard Micromist nebulizer (Glass Expansion, 
Australia). For size-exclusion chromatography, the eluent was split using a micro splitter 
valve (Upchurch Scientific, USA) with 30% directed to ICP-MS and the remainder to 
the ÄKTA 950 fraction collector where 500 μL fractions were collected in Deep Well 96 
well plates (Greiner, Germany). For anion exchange chromatography using the on-line 
ICP-MS, 80% of the eluent was collected in 680 μL fractions using an 1260 Infinity 
Analytical-Scale Fraction Collector (Agilent, Tokyo, Japan). The remaining 20% of 
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 the eluent flowed to the ICP-MS. 56Fe, 57Fe, 55Mn, 31P, and 34S were monitored with a 
dwell time of 100 ms. 
 
Chapter 4  LMM Mitochondria Methods  
Mitochondrial Isolation and LMM Fraction Preparation 
Mitochondrial purification and manipulations were carried out anaerobically in 
refrigerated Ar-Atmosphere gloveboxes to maintain native redox states. Yeast 
mitochondria were isolated from large scale (24L) liquid culture containing minimal 
media and glucose using a combination of enzymatic lysis and density 
ultracentrifugation described in Methods in Enzymology. Mitochondria from human 
Jurkat cells were also isolated from a large scale suspension culture and isolated using 
nitrogen cavitation and subsequent density ultracentrifugation as described 
previously.(106) Dissected mouse tissues from the brain and liver were separately 
homogenized, subjected to nitrogen cavitation, and mitochondria were purified using 
density ultracentrifugation as described previously.(107) All Purified mitochondria 
batches were washed 2-3x in 50mM Tris Buffer (pH 7.4) and then resuspended 1:1 (v/v) 
in 50mM Tris Buffer (pH 7.4) containing 2% Triton 100x. The sample was mixed for 15 
minutes. An aliquot of the mixture was removed and saved to determine total 
mitochondrial metal concentrations. The remaining mixture was then centrifuged at 
12,000xg for 15 minutes. The supernatant was transferred to an Amicon stirred cell 
concentrator containing a 10kDa cutoff membrane and the flow through was collected. A 
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 sample of the flow through was collected for each preparation to determine LMM metal 
concentration in the mitochondria.  
 
Chromatographical Separation of LMM Mitochondria Metal Species  
Samples (500µL) were in to the system previously described  LC-ICP-MS 
system using two in series Superdex peptide 10 x 300 mm columns as the stationary 
phase and 50mM Tris buffer  (pH 7.4) as the mobile phase. Elution was carried out at 
0.350 mL min-1 for a total of 2CV (50mL). Columns were regenerated with 10CV of a 
chelator cocktail described previously.(107) 
 
Elemental Analysis of “Complete” and LMM Mitochondrial Fraction  
Aliquots (75µL) of  complete and LMM fractions from each run were placed in 
individual 15mL Polypropylene nitric acid cleaned screw cap tubes along with 100 µL 
of concentrated TMG nitric acid and sealed. After samples were digested for 12hrs at 
90oC, samples were diluted to a total volume of 10mL for analysis by ICP-MS.  ICP-MS 
analysis was carried out in Helium collision mode on an Agilent 7700x ICP-MS. 
Concentrations were determined using calibration curves prepared from standards 
containing P, S, Mn, 56Fe, 57Fe, Co, Cu, and Zn. Absolute mitochondrial concentrations 
were calculated using measured dilution factors and known packing efficiencies.  
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 Chapter 5?6 Mice ??????? 
Animal Care and Dissections  
C57BL/6 mice were raised and manipulated in accordance with the TAMU 
Animal Care and Use committee (AUP 2010-226) for experiments involving organ 
development. ICR (Imprinting Control Region) outbred mice were raised and 
manipulated with the same AUP were utilized for LMM brain experiments. Mice were 
housed in disposable plastic cages (Innovive Innocage Static Short) with all-plastic water 
bottles and plastic feeders with zinc electroplated reinforcements. Mice were fed Fe-
deficient chow (Harlan Laboratories, Inc. Teklad ID TD.80396.PWD) supplemented as 
follows. For experiments involving 56Fe or 57Fe, the chow was supplemented with 50 
μg/g of either natural abundance Fe citrate or 57Fe citrate (IsoFlex USA) prepared as 
described. For each kg of chow, 22 mL of a 40 mM stock solution of Fe citrate (adjusted 
to pH 7) was added. The chow was further moistened with ca. 45 mL of double-distilled 
water containing 0.6 ng Fe/g water. The chow was compressed into pellets, heated at 100 
°C for 20 min, and then stored at −20 °C in zip-locked plastic bags. Samples of the 7 
batches of this chow examined contained an average of 33 ± 2 μg Fe/g chow as 
determined by ICP-MS.  
Fe-deficient pups were born to a mother that was fed the Fe-sufficient diet until 
~3 days prior to birth when her diet was switched to Fe-deficient (1.2 μg Fe/g chow). Fe-
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 deficient animals received water that was house-distilled, deionized using ion-exchange 
columns (Thermo Scientific 09-034-3), and distilled again using a sub-boiling still 
(Savillex DST-1000). The resulting sub-boiling distilled water contained 0.02 ng Fe/g 
water. 
Each cage contained ca. 200 g of synthetic bedding (Ketchum Omega Dry) with 
1.5 μg 56Fe/g. Nestlets (Ancare) that were included in the cages of pregnant females 
weighed ~10 g and contained 20 μg 56Fe/g. Nitrile gloves were worn when mice, chow, 
water, bedding, etc. were handled. So-called “56Fe-enriched” mice were treated 
equivalently but were raised on chow supplemented with natural-abundance Fe citrate. 
Mice were euthanized by an IP injection of a solution that provided 3 mg 
ketamine and 0.5 mg xylazine per 20 g body wt. Immediately after breathing ceased and 
the heart stopped beating, animals were imported into a refrigerated (5–10 °C) argon-
atmosphere glove box (MBraun Labmaster) containing between 2–20 ppm O2, where all 
dissections and tissue manipulations were performed. The “hands” of a pair of standard 
butyl rubber gloves on the box were cut off and replaced with tight-fitting surgical 
gloves using custom-designed plastic cuffs. The open end of each surgical glove was 
stretched over one end of a cuff and secured with two O-rings that fit into grooves on the 
cuff. The other end of the cuff was attached similarly to a butyl rubber glove, the other 
end of which was secured on the box glove port in standard fashion. 
Unless noted otherwise, animals were perfused with Ringer's buffer (155 mM 
NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 2 mM NaH2PO4, 10 mM HEPES, 10 mM 
glucose, and ~10 U heparin/mL). A 27 gauge 1/2” long stainless-steel needle was 
36 
 
 inserted into the left ventricle of the heart, and buffer was pumped at ca. 0.7 mL min−1. 
After ensuring proper placement of the needle, the caudal vena cava was severed, and 
pumping continued for an additional 1–2 min until blanching of the liver appeared 
complete. For some dissections, blood diluted with Ringer's buffer was collected. 
Immediately after perfusion, brains and other organs were isolated by dissection 
using stainless steel and/or titanium instruments. The Fe concentration of a 50 mL 
solution of Ringer's buffer into which the stainless steel instruments were immersed for 
30 min increased by 190 nM. This is far longer than animals contacted the instruments. 
Thus, an insignificant amount of Fe was leached from these instruments during 
dissections and none of the Fe-associated features observed in the spectra originated 
from them. 
 
Preparation of LMM Brain Extract 
Animals were perfused with degassed heparinized Ringer's buffer at 1.0 mL 
min−1 for 0.5 min g−1 mouse, and then dissected as described.6 Immediately after 
isolation, 3–4 brains were added to a known volume (2–3 mL) of degassed 20 mM Tris 
buffer (pH 7.4). The solution was homogenized for 1 min using a plastic rotary knife 
inserted into a tissue grinder (Omni TH). The resulting homogenate was disrupted by 
nitrogen cavitation (model 4639, Parr Instruments) at 800 psi for 10 min. The resulting 
extract was treated with Triton X-100 and Sodium deoxycholate (final concentrations of 
1% (v/v) and 1% (w/v), respectively) for 10 min. The sample was removed from the box 
in an air-tight centrifuge bottle and spun at 110 000× g for 30 min. The bottle was 
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 returned to the box and the resulting supernatant fraction ( 3 mL) was transferred to a 
stirred cell concentrator (Amicon Model 8003, Millipore) fitted with a 10 kDa cutoff 
membrane (YM-10, Millipore). The supernatant was passed through the membrane with 
a head pressure of 90 psi Ar, and 2 mL of the flow-through solution (FTS) was 
collected in a plastic screw-top tube. The tube was sealed with electrical tape, placed 
inside of a second container that was then sealed, removed from the box, and 
immediately imported into a second glovebox that contained the LC. In one experiment, 
the FTS was split into two aliquots, one of which was spiked with 100 μL of 180 nM 
stock solutions (prepared in 20 mM Tris pH 7.4) of FeSO4, CuCl2, MnCl2, CoCl2, ZnCl2 
and Na2MoO4. After 3 h, aliquots were injected, one after the other, into the LC-ICP-MS 
system. 
 
Elemental Concentrations in Flow-Through Solutions 
Aliquots (150 μL) of the FTS for each run were placed into 15 mL plastic screw-
top tubes (BD Falcon) containing 100 μL of concentrated trace-metal-grade (TMG) 
nitric acid (6.4 M final concentration). After 12 hr at 90 °C, samples were diluted with 
9.75 mL of distilled-and-deionized water, affording a final acid concentration of 0.14 M. 
Calibration curves were prepared from standard solutions containing P, S, Co, Cu, Zn, 
Fe, Mn, and Mo (Inorganic Ventures, Christiansburg Virginia, USA) at known 
concentrations, prepared in trace-metal-grade nitric acid and diluted using distilled-and-
deionized water. Data were collected in He collision mode using an inductively coupled 
plasma mass spectrometer (ICP-MS, model 7700x, Agilent Technologies, Tokyo, 
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 Japan). Elemental concentrations were determined using the calibration curve. Values 
obtained were adjusted for dilution factors. 
 
Chromatography Instrumentation 
HPLC separations were carried out in a refrigerated Ar-atmosphere glove box 
(Labmaster, Mbraun, USA) using an Agilent 1200 Bioinert LC composed of a metal-free 
Infinity 1260 Quaternary Pump equipped with a manual injection valve fitted with a 500 
μL PEEK injection loop. Two size-exclusion Superdex Peptide GL 10/300 columns (300 
× 10 mm, GE Life Science, USA) were combined in series using a male-to-male union 
connector. The mobile phase was 20 mM Tris buffer (pH 7.4). Post-column eluent flow 
(0.35 mL min−1) was mixed in real-time with a solution of 4% trace-metal-grade nitric 
acid plus 100 μg L−1 116In, diluting the eluent 2-fold. The resulting solution flowed into 
the ICP-MS in an on-line configuration, and 31P, 34S, 55Mn, 63Cu, 59Co, 65Zn, 95Mo, 56/57Fe, 
and 116In were detected. Indium was used as an internal standard to monitor plasma 
suppression. Other ICP-MS conditions: RF power, 1500 W; Ar flow rate, 15 L min−1; 
collision cell He flow rate, 4.3 mL min−1; sampling/skimmer cones, Pt, Pt; dwell time, 
0.2 s; internal standard pump rate, 0.35 mL min−1. 
The column was cleaned after each run using 10 column volumes (CVs) of a 
chelator cocktail at a flow rate of 150 μL min−1 and then regenerated with the elution 
buffer (20 mM Tris, pH 7.4). The chelator cocktail was composed of 20 mM Tris pH 8.0 
plus 10 μM each of ethylenediaminetetraacetic acid (EDTA), ethylene glycol tetraacetic 
acid, tetrakis-(2-pyridylmethyl)ethylenediamine (TPEN), Phen and 2,2′-bipyridine. 
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 Molecular Mass (MM) Calibration 
The MM associated with each chromatographic peak was calculated using a 
standard curve constructed from 14 known species. Standard stock solutions were 
prepared in 20 mM Tris pH 7.4, affording concentrations ranging from 1–200 μM. Each 
solution was injected individually onto the column. Elution volumes Ve were determined 
using either the ICP-MS or UV-vis detector response. In cases where multiple forms 
were evident (GSH, GSSG, ATP, ADP, and AMP), the peak with the MM nearest to the 
known mass of the species was assigned to that species. Void volume V0 was determined 
using Blue Dextran (MM 2000 kDa). The logarithm of the MM was plotted vs. the ratio 
Ve/V0 . The best-fit linear regression curve was constructed through the data points. 
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 CHAPTER III 
INSIGHTS INTO THE IRON-OME AND MANGANESE-OME OF ΔMTM1 
SACCHAROMYCES CEREVISIAE MITOCHONDRIA* 
 
Introduction 
The Mtm1p protein found in the budding yeast Saccharomyces cerevisiae is a 
member of the mitochondrial carrier family.(108, 109) Located in the mitochondrial inner 
membrane (IM), members of this family transport low-molecular-mass (LMM) species 
between the cytosol and the matrix of the organelle. The substrate transported by Mtm1p 
has not been identified and so the exact cellular function of the protein is unknown. 
Carriers can be organized according to whether their substrates are nucleotides, 
carboxylates, or amino acids, with Mtm1p in the last group.(110) Substrates tend to be 
negatively charged and carriers often catalyze an exchange in which protons move in 
opposition to substrates.  
Deleting the MTM1 gene partially inactivates Mn superoxide dismutase 
(MnSod2p),(108, 111) suggesting that Mtm1p might be involved in Mn metabolism. During 
maturation, apo-Sod2p is sent to the mitochondrial matrix where Mn is installed during 
folding, suggesting that Mtm1p either imports Mn or is a chaperone for that installation. 
* This chapter is reproduced in part with permission from “Insights into the iron-ome and manganese-ome
 of Δmtm1 Saccharomyces cerevisiae mitochondria” by Jinkyu Park, Sean P. McCormick, Myrinmoy 
Chakrabarti, Paul A. Lindahl, 2013, Metallomics, 5, 656-672, copyright 2013 Royal Chemical Society  
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 However, the Mn concentration within Δmtm1 mitochondria is elevated relative to that 
of WT mitochondria,(108) discounting the possibility that Mtm1p imports Mn. 
Attention shifted to Fe metabolism when Sod2p was found to be inactivated in 
association with an elevation of Fe in Δmtm1 cells.(108, 111) Genetic and chromatographic 
results suggest that an Apo-Sod2p-Reactive (ASR) pool of Fe in the matrix (referred to 
as FeASR) competes with Mn ions for installation into the active-site of apo-Sod2p. 
Indeed, Fe misincorporates into superoxide dismutases, a process that prevents the apo-
enzyme from being activated by Mn.(112) The size of the Mn pool in yeast mitochondria 
varies with the concentration of Mn in the growth medium.(108) The mitochondrial Fe 
concentration increases under Mtm1p-deficient conditions. 
The extent of Fe misincorporation appears related to the Fe concentration in the 
growth medium, in that Fe-deficient conditions (created by adding the chelator 
bathophenanthroline disulfonate) prevent both Fe accumulation and loss of SOD2 
activity in Δmtm1 mitochondria.(111) Misincorporation is also prevented by additionally 
deleting MRS3/4, the genes encoding high-affinity Fe transporters on the mitochondrial 
IM.(111) This suggests that the FeASR pool enters the mitochondria through Mrs3p/4p. 
A single Mn species, associated with MnSod2p, was identified in fractions 
obtained by passing WT mitochondrial extracts through an anion-exchange column;  no 
such species was observed with Δmtm1 extracts. Replacing this peak in chromatograms 
of Δmtm1 mitochondrial extracts was a dominating Fe peak that co-eluted with Sod2p. 
This peak, attributed to FeSod2p, was absent in extracts of a Δmtm1 Δsod2 double-
deletion mutant. This was the only Fe-containing peak evident in soluble Δmtm1 
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 extracts, and the peak was absent in WT extracts. This suggested that the majority of the 
soluble Fe in Δmtm1 mitochondrial extracts that eluted through the column was 
misincorporated into apo-Sod2p. 
The situation is actually more complicated in that a deficiency of Mtm1p is not 
unique in causing Fe to accumulate or misincorporate.(111) Depleting the cell of Ssq1p, 
Grx5p, and Atm1p also causes Fe to accumulate in mitochondria and Sod2p to partially 
inactivate. These proteins are involved in mitochondrial Fe metabolism, but they have 
distinct functions. Ssq1p is a soluble Hsp70-family chaperone that helps install nascent 
Fe/S clusters into recipient apo-Fe/S proteins.(113) Atm1p is a mitochondrial IM ABC 
transporter that exports an unknown sulfur-containing species required for cytosolic Fe/S 
cluster assembly.(114) Grx5p is a monothiol glutaredoxin that binds the scaffold proteins 
Isa1p/Isa2p.(115) Based on these diverse functions, it would appear that neither apo-
Sod2p-misincorporation nor Fe accumulation in mitochondria are primary effects of 
Mtm1p deficiency. Rather, they appear to be secondary effects arising in mitochondria 
lacking Mtm1p, Grx5p, Ssq1p, or Atm1p. 
Another complexity is that Fe accumulation and misincorporation appear to be 
independent of each other. The absence of certain mitochondrial proteins, e.g. yeast 
frataxin homolog Yfh1p(116) and the scaffold protein Isu1p, cause Fe accumulation but 
not misincorporation. Interestingly, the proteins which, when depleted in cells, cause Fe 
to accumulate but NOT misincorporate (e.g. Yfh1p and Isu1p) help build Fe/S clusters. 
In contrast, proteins which, when lacking, cause both Fe accumulation AND 
misincorporation (i.e. Atm1p, Grx5p, and Ssq1p) may help transfer assembled clusters 
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 into recipient apo-proteins.(98) This correlation implies that Mtm1p functions in cluster 
transfer, not assembly. The misincorporated Fe has been proposed to originate from the 
Fe/S cluster donated by Isu1p. This is consistent with the increased level of Isu1p in 
Δmtm1 cells relative to in WT cells(98, 117) in that the cell may compensate for a 
deficiency of Fe/S clusters by increasing Isu1p levels. 
Another complexity in understanding the Δmtm1 phenotype is that the type of Fe 
that accumulates in Atm1p-depleted mitochondria (and in Δyfh1 and Yah1p-depleted 
mitochondria) is ferric oxyhydroxide (phosphate or polyphosphate) nanoparticles.(118-120) 
This insoluble form of Fe seems unlikely to insert into apo-Sod2p; we would expect that 
soluble FeII ions insert. Also, the size of the FeASR pool is unknown. It should enlarge in 
strains lacking Mtm1p, Atm1p, Grx5p, and Ssq1p, relative to in WT cells, but there is no 
certainty that the majority of the Fe that accumulates in the mitochondria of these strains 
is that particular pool of Fe. 
To address this question, X-ray absorption spectroscopy (XAS) was performed 
on Δmtm1 mitochondria as well as on mitochondria from a control mutant (rho−) that 
also accumulates Fe but exhibits normal SOD2 activity when the growth medium is 
supplemented with 2 mM Fe.(98) No difference in the properties of the accumulated Fe, 
including oxidation state, geometry, or ligand environment, could be discerned. This 
suggests that the FeASR pool that misincorporates into apo-Sod2p must be quite small – so 
small that it is undetectable by XAS. 
Mtm1p has also been suggested to function in heme biosynthesis. One of the five 
mitochondrial proteins that coexpresses with other proteins involved in heme 
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 biosynthesis in zebrafish is an ortholog of yeast Mtm1p.(117) Silencing this gene 
prevented Fe incorporation into protoporphyrin IX. This suggests that this Mtm1p-like 
protein is involved early in heme biosynthesis, i.e. prior to insertion by ferrochelatase, 
perhaps by regulating d-aminolevulinate synthase, the committed step in heme 
biosynthesis. 
Previously, we studied the iron-ome of mitochondria from WT and mutant 
strains related with mitochondrial Fe/S and heme biosynthesis.(119-121) The iron-ome of 
fermenting WT mitochondria is mainly composed of Fe/S clusters, heme centers, HS 
FeII/III, and FeIII nanoparticles. However, mutant mitochondria commonly exhibit a 
dominant FeIII nanoparticle feature, and are largely devoid of intact Fe/S clusters and 
heme centers. In this paper, we describe the iron-ome of mitochondria from Δmtm1 yeast 
using biophysics and liquid chromatography (LC) in conjunction with an on-line 
inductively coupled plasma mass spectrometer (ICP-MS). Similarly to the previous 
studies, most of the accumulated Fe is present as FeIII oxyhydroxide nanoparticles, which 
is unlikely to misincorporate into apo-Sod2p. LMM Mn and Fe species were observed in 
mitochondrial extracts that could potentially represent the sought-after pools. An Fe-
containing protein comigrated approximately with MnSOD-containing fractions, but the 
relative level of this protein was similar in both WT and Δmtm1 mitochondria. We 
conclude that deleting MTM1 diminishes SOD2 activity in a manner that does not 
involve Fe misincorporation, and suggest alternative cellular functions for this protein. 
This chapter summarizes the LC-ICP-MS experiments used to investigate the 
role of the MTM1 protein on both Fe and Mn metallomes. Dr. Jinkyu Park, who was a 
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 graduate student in the lab, was primarily responsible for the studies involving the Mtm1 
strain. My role on this study was to setup, operate, and maintain the LC-ICP-MS system, 
help run the separations and collect the data, and analyze the results we obtained.  I also 
participated in the broader discussions on this project.  
 
Results  
Initial experiments conducted by Dr. Park, were unable to located the speculated 
pool of “bioavailable” iron FeARS or the misincorporation of iron into the SOD protein. It 
was at this point in which it was decided LC-ICP-MS may be able to assist in addressing 
these hypothesis.  Soluble WT and Δmtm1 fractions were subjected to liquid 
chromatography, and the eluent was monitored for metal ions using ICP-MS. In most 
experiments, the ICP-MS was configured on-line, such that the eluent was split, with a 
portion flowing into fractions and the remainder to the ICP-MS in real time during the 
chromatography run. In off-line experiments, the entire eluent was fractionated, and 
fractions were individually analyzed by ICP-MS.  
The A280 trace of the eluent off the Superdex column (not shown) indicated that 
>90% of the protein in the soluble samples eluted in the void volume. This volume was 
ca. 46 mL and corresponded to molecular masses >600 kDa. Also eluting in the void 
volume was a small proportion of the Mn in the injected sample (Figure 3.1.a and b, 
upper traces). Two major Mn peaks were observed in later fractions, called Mn100 and 
Mn2-3, with molecular masses of ca. 100 kDa and <10 kDa respectively (Figure 3.1.a and 
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 b). Mn100 co-eluted with active tetrameric Sod2p while Mn2-3 corresponded to the LMM 
species. 
We have sufficient information to roughly estimate the speciation of Mn in 
mitochondria. In WT mitos grown on normal medium, ca. 64% of the soluble Mn was 
SOD2-associated. Thus, ~24% (0.64 × 38%) of total Mn ions in the original 
mitochondrial sample was associated with 28% of the total SOD2 activity. The similarity 
of these two numbers suggests that the remaining 72% of MnSod2p in the pellet 
represented another 62% of the Mn in WT mitochondria. Thus, the majority of the Mn in 
these organelles (28% + 62% = 90%) appears to be associated with MnSod2p. Mn2-3 
represented 32 ± 3% of the soluble Mn in our WT samples, corresponding to 12% (0.32 
× 38%) of total WT mitochondrial Mn. These results indicate that the Mn in WT 
mitochondria is distributed into two species – ca. 90% is associated with MnSod2p and 
ca. 10% is present as soluble LMM species. 
In Δmtm1 mitochondria, about 45% of total Mn was soluble. Of this, 89% was 
LMM and 9% was associated with MnSod2p. Only ca. 4% of total Mn in Δmtm1 
mitochondria was in the form of soluble Sod2p, and this corresponded to 26% of total 
SOD2 activity. The other 74% of the Sod2p protein (in the pellet) must have included 
another 12% of the total Mn. Thus, 15% of total Mn in Δmtm1 mitochondria (4% + 
11%) was probably MnSod2p-associated. The only other species observed in the soluble 
fraction was Mn2-3, suggesting that >80% of the Mn in Δmtm1 mitochondria arise from 
LMM species. As mentioned above, the concentration of Mn in Δmtm1 mitochondria 
was about twice that of WT mitochondria. Our analysis indicates that most of the  
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Figure 3.1.  Mn and Fe traces from SEC-ICP-MS chromatography of soluble fractions of 
W303 and Δmtm1 mitochondria. (a) HMM chromatograms of W303 mitochondria; (b) 
HMM chromatograms of Δmtm1 mitochondria, Experiment 1. Red solid lines simulate 
Mn and Fe species that co-eluted with Sod2p. The inset shows images of SOD2 activity 
gel, Western blot membrane against Sod2p for each fraction labeled with fraction 
volume, and SOD2 unit activities determined spectrophotometrically. Metal peaks were 
labeled according to their approximate molecular weight. Molecular mass was 
determined using a calibration plot for the Hi-Load Superdex 200 column. (c) LMM 
chromatograms of W303 (top) and Δmtm1 (bottom) mitochondria, Experiment 4. 
Chromatographic intensities were adjusted proportionally to mitochondrial LMM Mn 
and Fe concentrations, and then WT-Mn and Δmtm1-Mn were amplified 20-fold for 
easier comparison. 
48 
 
 additional Mn in Δmtm1 mitochondria was present as Mn2-3. Also, the MnSod2p protein 
level in Δmtm1 mitochondria was diminished relative to WT levels. Assuming 13 μM 
[Mn] in WT mitochondria, this corresponds to 12 μM MnSod2p and 1 μM Mn2-3. In 
Δmtm1 mitochondria, with 26 μM [Mn], we calculate 4 μM MnSod2p and 22 μM Mn2-3. 
Thus, deleting MTM1 caused a 3-fold reduction in active MnSod2p and a 22-fold 
increase in the size of the LMM Mn pool in the mitochondria. 
In the second experiment, for mitochondria isolated from WT cells grown on 
medium supplemented with 200 μM MnCl2, the Mn trace (Figure 3.2) again showed two 
major peaks, Mn100 (23%) and Mn2-3 (68%). In this case, 15% of the total Mn in the 
sample was soluble, and of this, 23% corresponded to MnSod2p. This means that 0.23 × 
15% = 3.5% of total Mn in the sample corresponded to 10% of the SOD2 activity. The 
remaining 90% of the activity must have represented another 31% of total Mn. Thus, 
nearly 35% (3.5% + 31%) of total Mn in the sample was associated with MnSod2p. The 
only other species present in the chromatogram was Mn2-3, suggesting that it 
corresponded to the remaining 65% of the total Mn in WT mitochondria grown on 
excess Mn. With 35 μM = [Mn], we conclude that 12 μM was MnSod2p and 23 μM was 
Mn2-3. Thus, the MnSod2p level remained about the same while the LMM Mn pool 
increased dramatically. Thus, the size of the LMM Mn pool in mitochondria is sensitive 
to the Mn concentration in the medium. 
Finally, we consider the Mn distribution in mitochondria from Δmtm1 cells 
grown on 200 μM Mn (Figure 3.2). In this case, Mn100 represented 5% of the Mn in the 
chromatogram while Mn2-3 was 94%. 28% of total Mn was soluble, and so (0.05 × 28% 
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 =) 1.4% of total Mn corresponded to 31% of MnSOD2 activity. The remaining 69% of 
the SOD activity must correspond to another 3.1% of the total Mn in the sample, 
suggesting that 4.5% of total Mn was MnSod2p. The sample had 80 μM Mn, and so 
there was 4 μM (80 × 0.045) MnSod2p in mitochondria from Δmtm1 cells grown with 
200 μM Mn. The remaining 76 μM was associated with Mn2-3. This analysis indicates 
that the concentration of MnSod2p did not change with Mn supplementation in the 
growth medium, but that the LMM Mn pool concentration increased more than 2-fold. 
The results of these calculations are visually summarized in Figure 3.3. 
The corresponding Fe traces exhibited 7 distinguishable features, with significant 
concentrations in the void volume (FeH), 5 minor-intensity peaks in the central region 
(Figure  3.1 a and b, lower traces; F200, Fe100, Fe60, Fe35, and Fe20), and an intense LMM 
feature (Fe3) that has a slightly higher mass than Mn2-3. Fe3 is a viable candidate for 
FeASR. For the first two experiments, an average of 25% of the total Fe was solubilized 
from mitochondrial extracts. Of this, FeH represented 67% of total mitochondrial Fe in 
one experiment and 17% in the other. The Fe3 intensity corresponded to 19% of total Fe 
in the first experiment and 74% in the second. Despite the large variations, these two 
peaks collectively dominated the Fe chromatograms of soluble WT mitochondrial 
extracts. The intermediate-molecular-mass (IMM) Fe species corresponded to ca. 10% 
of the soluble Fe – representing 2.5% of the total Fe. With a total Fe concentration of 
880 μM in WT mitochondria, these IMM Fe species were present at ca. 20 μM 
collectively, with Fe100 corresponding to a concentration of ca. 9 μM. 
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 An average of 7% of total Fe was solubilized in the corresponding Δmtm1 
mitochondria samples. Since the Fe concentration in these mitochondria was 3500 μM, 
this corresponded to 245 μM Fe injected onto the column. FeH and Fe3 again dominated 
the chromatograms. Fe100 represented 2% of the overall chromatogram intensity, 
corresponding to a concentration of 5 μM. Thus, upon deleting MTM1, Fe100 declined 
nearly 2-fold. 
Under high Mn nutrient conditions, 14% of WT mitochondrial Fe was 
solubilized; this corresponded to 87 μM Fe (620 μM × 0.14) in the soluble sample. Fe100 
represented 3% of that Fe (ca. 3 μM). For Δmtm1 mitochondria, 8% of mitochondrial Fe 
was solubilized. At 5200 μM Fe, this corresponded to 416 μM soluble Fe loaded on the 
column. Fe100 represented 0.4%, corresponding to 2 μM. Thus, deleting MTM1 under 
high Mn caused a slight decline of Fe100. This was the same qualitative effect as seen 
under normal Mn growth conditions. 
Fe100 approximately coeluted with Mn100 raising the possibility that it 
corresponded to FeSod2p. The absolute concentration of Fe100 in mitochondria and the 
percentage of Fe that it represented would indeed make it impossible to detect by either 
Mössbauer or XAS spectroscopies. If the percentage of Fe-misincorporated Sod2p is 
defined as = 100[Fe100]/([Fe100] + [Mn100]), then the percentage of FeSod2p was 75 ± 4% 
and 79 ± 3% for WT and Δmtm1 mitochondria (average of 3 experiments). Assuming 
that Fe100 corresponds to FeSod2p, these percentages show that there was no significant 
difference in the extent of Fe misincorporation into apo-Sod2p between WT and Δmtm1 
mitochondria. Although these results cannot exclude the possibility that Fe100 
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 corresponds to FeSod2p, the results of other LC experiments (e.g. see Figure 3.5) 
discount this possibility. Thus, we suggest that only minor portions of Sod2p in our WT 
and Δmtm1 preparations may be misincorporated with Fe. 
We performed SOD2 activity gels and Western blots against Sod2p using pooled 
Sod2p-containing fractions and as-isolated mitochondria. In all three experiments, 
pooled fractions of SOD2-active Δmtm1 extracts revealed specific activities 
corresponding to 100 ± 14% of WT levels. This again indicated that the extent of Fe-
misincorporation in Δmtm1 and WT cells is similar. 
The situation was different using isolated mitochondria. The SOD2 specific 
activity of Δmtm1 mitochondrial extracts, prepared from cells grown without Mn 
supplementation, was ca. 20% of the SOD2 specific activity of equivalent WT 
mitochondrial extracts. This suggested that a large percentage of Sod2p in Δmtm1 
mitochondria is inactive but is not associated with the MnSod2p in the Mn100-
containing fractions. The inactive Sod2p probably migrates differently through the 
column or remains in the pellet during solubilization. We performed Western blots on 
various fractions that eluted from the column, but could not identify any that contained 
Sod2p, suggesting that the inactive form is in the pellet. This form could be Fe-
misincorporated, misfolded or modified in some manner. 
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Figure 3.2. Mn and Fe traces from Experiment 2 (200 µM MnCl2 supplimented in 
media) of the first group of LC-ICP-MS studies. The inset shows the SOD2 activity gels. 
Western blots against Sod2p and SOD2 activity unites determined spectrophometrically. 
(a) W303; (b) ∆mtm1 
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Figure 3.3. Visualization of Mn distribution. Left side, concentrations of MnSod2p 
(circles) and Mn2-3 (stars) in intact mitochondria from WT and Δmtm1 cells grown on 
media with ~2 and 200 μM Mn. Right side, the Mn content of corresponding 
mitochondrial extracts after sonication and centrifugation. Each circle and star represents 
1 μM Mn concentration.   
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 There was some recovery in SOD2 specific activity in mitochondria isolated 
from cells grown on Mn supplemented medium, similar to that reported previously.1 In 
this case, the SOD2 specific activity of Δmtm1 mitochondria was ca. 70% relative to WT 
mitochondria. This might be caused, not by an increase of MnSod2p, but a decrease in 
Sod2p expression such that only ~30% of Sod2p in Δmtm1 mitochondria is inactive. 
Further studies are required to examine this possibility. 
 
LC-ICP-MS of LMM Species 
We initially collected the Mn2-3 and Fe3 fractions from the first group of 
experiments, and subjected them to the LMM size-exclusion column to determine their 
molecular masses with greater accuracy. The results indicated multiple overlapping 
species, with poor reproducibility from batch to batch. More consistent (and simpler) 
results were obtained by disrupting isolated mitochondria by adding detergent 
(deoxycholate) rather than by sonication. Supernatant fractions were passed through the 
10 kDa cut-off membrane and the flow-through was injected onto the column. Mn2-3 and 
Fe3 dominated (Figure 3.1 c, Experiment 4), and they eluted in accordance with 
molecular masses between 2–3 kDa (explaining the subscripts used). Taken together, 
these results suggest that the major LMM Mn and Fe species in yeast mitochondria have 
similar ligand environments (at least in terms of the collective masses of the ligands).  
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 Anion Exchange Chromatography 
We repeated previous LC experiments using the same column (MonoQ) and run 
conditions (except that we performed our LC under anaerobic conditions). Due to the 
high salt concentration involved at the end of the gradient, individual fractions were 
analyzed (after dilution) for metals using the ICP-MS off-line. Soluble mitochondrial 
extracts from sonicated WT and Δmtm1 mitochondria afforded an intense Mn peak at 
~14 mL, another less intense peak (or group of incompletely resolved peaks centered) at 
~19 mL, and unassigned peaks at 2, 36, and 62 mL (Figure 3.4, Experiment 5). We 
tentatively assign the dominant peak to Mn2-3, based on results of the LMM size-
exclusion study in which MnSod2p and Mn2-3 peaks dominated. SOD2 activity assays 
and Western blots against Sod2p demonstrated that Sod2p co-eluted with the second 
peak(s) (Figure 3.4, insets i, ii). The specific SOD2 activity in the five fractions 
containing most Sod2p was 2-fold lower in Δmtm1 than in WT fractions, suggesting that 
one or more inactive forms of Sod2p co-eluted with the active form. The Fe 
concentrations in these fractions were also determined. One major Fe peak was observed 
in both Δmtm1 and WT chromatograms, which we tentatively assign to Fe3, with similar 
justification. There were low intensity features in the vicinity of the SOD2-active Mn 
peaks (Figure 3.4, insets iii, iv), but nothing that comigrated exactly with the SOD2-
active fractions or with an intensity that would suggest massive Fe-misincorporation.  
The experiment was repeated but using a shallower salt gradient and with the 
ICP-MS on-line. Sod2p and SOD2 activity co-eluted with Mn around 30 mL in both of 
WT and Δmtm1 chromatograms (Fig. 3.5, Experiment 6) whereas the nearest Fe species 
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 eluted at a somewhat greater elution volume. These results again indicate that the extent 
of Fe mis-incorporation is not significant in Δmtm1 cells, and is no greater than in WT 
cells. SOD2 activity is diminished in Δmtm1 mitochondria, but not because of excessive 
Fe-misincorporation. 
The Sod2p in fractions collected from the MonoQ column migrated in four 
different positions in native gels (see Figure 3.5b, bottom insets). Sod2p is active as a 
homotetramer,1 suggesting that subunits may have different charge, with each 
combination migrating slightly differently through the column. The situation differs for 
Sod2p in fractions from size-exclusion columns (Figure 3.5a), because the molecular 
masses of the different tetrameric forms are so similar. Sod2p tetramers in earlier Mono 
Q fractions are less negatively charged, and more Sod2p in Δmtm1 mitochondria eluted 
earlier compared with WT mitochondria. Although most Sod2p eluted at ~30 mL 
(Figure 3.5), an Sod2p band was observable down to 20.6 mL (0.14 M NaCl) in the 
Δmtm1 chromatogram (Figure 3.5b), whereas Sod2p was visible only down to 24.7 mL  
(0.17 M NaCl) in the WT chromatogram (Figure 3.5a). This suggests that Sod2p might 
acquire a charge-altering post-translation modification such as phosphorylation, and that 
this process is somehow diminished in Δmtm1 mitochondria. Consistent with this, 
threonine (T147 and T149) residues in Sod2p can be phosphorylated. 
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Figure 3.4. Off-line ICP-MS anion-exchange chromatograms of soluble W303 and 
Δmtm1 mitochondria, Experiment 5. (A) dotted line, salt gradient; (B) W303, Mn 
concentrations in eluted fractions; (C) Δmtm1, Mn; (D) W303, Fe; (E) Δmtm1, Fe. Insets, 
(i) W303, SOD2 activity gel and Western blot membrane against Sod2p from five 
adjacent fractions containing most Mn (top), SOD2 unit activity from corresponding 
fractions (bottom); (ii) Δmtm1, same as (i); (iii) W303, close-up view of Mn and Fe 
profiles in 16–23 mL region; (iv) Δmtm1, same as (iii).   
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Figure 3.5  On-line anion-exchange chromatograms of soluble (a) W303 and (b) Δmtm1 
mitochondria in Experiment 6. Salt gradient is shown as the dashed lines above the data. 
Mn detector responses are multiplied by 10. Insets, SOD2 unit activity of the 15 
fractions centered at 30 mL (above Fe trace); images of SOD2 activity gel and Western 
blot membrane against Sod2p (below Mn trace), from every other fraction in 16–28 mL 
(left), from five adjacent fractions (28–31 mL) containing most Mn (right). Differently-
migrating MnSod2p bands in native gel are indicated by arrows above the lane 
exhibiting a differently charged form (reading from right to left). Contrast for the 
Western blots of the 16–28 mL fractions are greater than for the 28–31 mL blots.   
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 Discussion  
The early studies by Dr. Park suggested that FeASR should be present at very low 
concentrations with no chance of being characterized or even detected by Mössbauer 
spectroscopy. Thus, we turned our attention to LC-ICP-MS with the goal of identifying 
FeASR and the Fe-mismetallated FeSod2p. We regard Fe3 as a viable candidate for FeASR, 
because it is a LMM species with a molecular mass similar to that of Mn2-3. In this case, 
the mismetallation reaction would be 
 
FeII L3 + apo-Sod2p → L3 + FeSod2p 
 
The most likely candidate for FeSod2p was Fe100, based on molecular mass. 
However, the fraction of mismetallated Sod2p present in Δmtm1 mitochondria, assuming 
Fe100 to be this species, was no different than in WT mitochondria. This was unexpected, 
and it casts doubt on this assumption. 
We were also unable to reconcile our size-exclusion LC-ICP results with a 
previous study. The previous MonoQ chromatograms of WT mitochondrial extracts 
displayed only one Mn peak (MnSod2) which was absent in chromatograms of Δmtm1 
mitochondria. In contrast, we observed the MnSod2 peak in chromatograms from both 
WT and Δmtm1 mitochondria. Moreover, our chromatograms exhibited a second major 
Mn species that has not been observed previously. 
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 In the earlier study, no Fe peaks were observed in the WT chromatogram while 
two Fe peaks were observed in the Δmtm1 chromatogram (one that comigrated with 
Sod2p and one that eluted in the void volume). We observed a major Fe species in both 
WT and Δmtm1 chromatograms that did not comigrate with Sod2p, as well as minor Fe 
peaks that comigrated in the vicinity of MnSod2p. We did not observe an Fe species that 
comigrates precisely with MnSod2p. We cannot explain these differences. In the 
previous study, the bulk of Fe in Δmtm1 mitochondria was concluded to be associated 
with Sod2p (as FeSod2p). Based on our results, we conclude that only a tiny amount of 
mitochondrial Fe could be associated with Sod2p, and that the level of FeSod2p in 
Δmtm1 cells is similar to that in WT cells. 
Observed differences may arise from differences in the yeast strain (W303 vs. 
BY4741), growth medium (minimal vs. YPD), growth conditions or preparation 
methods, but we have no supporting evidence for any of these possibilities. It is also 
possible that additional FeSod2p formed in Δmtm1 mitochondria but that it was less 
stable than MnSod2p and that it localized primarily in the pellet of our samples. 
However, yeast FeSod2p is sufficiently stable and soluble for crystallization studies, 
casting doubt on this explanation. 
Determining the function of Mtm1p – defined by the species transported by this 
IM mitochondrial carrier – is a continuing challenge. Our results suggest that the lower 
SOD2 activity observed in Δmtm1 S. cerevisiae arises, not because of excessive 
mismetallation, but because a significant portion of Sod2p is misfolded or degraded, 
and/or because the expression-level of SOD2 is diminished. One possibility is that 
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 Mtm1p imports a Maturation Factor (MF) required to help mature apo-Sod2p (Figure 
3.6). Other proteins that exhibit this phenotype (Ssq1p, Grx5p and Atm1p) might also be 
involved in apo-Sod2p maturation, which includes installing Mn and folding the protein. 
In the absence of Mtm1p (or these other proteins), the rate of maturation might slow 
such that apo-Sod2p misfolds or does not become metallated as fast as observed in WT 
cells. The slow rate of maturation might cause the Mn species that is used for metallation 
(e.g. Mn2-3) to accumulate. Under Mn-supplemented conditions, this Mn species would 
be imported at a greater rate.  
Another possibility, suggested by the results of Figure 3.5, is that Mtm1p helps 
regulate MnSod2p activity and/or stability by promoting a reaction that affects the 
charge on the protein. Phosphorylation reactions are used to regulate numerous 
mitochondrial enzymes,(122, 123) and are involved in the H2O2 stress response.
(124) Our 
results are consistent with the possibility that in the absence of Mtm1p, the degree of 
phosphorylation declines. However, further studies are required to interpret these results 
more definitively. 
In WT cells, Sod2p is mainly metallated with Mn. Fridovich purified Sod2p from 
S. cerevisiae, and found sufficient Fe in the purified Mn-protein solution for no more 
than 6% of it to be Fe-bound.(125) Approximately 80% of the Sod2p isolated by 
Whittaker and Whittaker(126) from the same organism contained Mn, with ~20% 
containing Fe. Jeong et al.(127) purified the Sod2p from the closely-related 
Schizosaccharomyces pombe and was unable to detect any Fe (or Cu, Zn, or Ni) in the 
purified enzyme; the only metal detected was Mn.  
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Figure 3.6  Model of Mtm1p Function. Mtm1p as an importer of a factor (presumed to 
be a small molecule) that helps mature apo-Sod2p, perhaps involving Mn insertion or 
protein folding. In the absence of Mtm1p, the rate of maturation slows which causes a 
build-up of MnASR and immature Sod2p that eventually misfolds. The lack of functional 
MnSod2p increases the concentration of ROS in the matrix, which triggers the Fe 
accumulation phenotype.   
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 On the other hand, Kang et al.(128) determined the X-ray diffraction crystal structure of 
the Fe-metallated S. cerevisiae Sod2p to 1.79 Å resolution. In cell grown under normal 
conditions, the extent of mismetallation seems to vary from 0% to 20%. The 
mismetallated protein used for crystallography was obtained by overexpressing yeast 
apo-Sod2p in E. coli grown in medium supplemented with 100 μM Fe, which may have 
increased the level of mismetallation. Using Mössbauer spectroscopy, Fleischhacker et 
al.(129) found that 40% of the Fe in whole E. coli cells (grown on medium supplemented 
with just 10 μM 57Fe) was mononuclear NHHS FeII. Higher levels of such Fe might be 
present in cells grown with 100 μM Fe in the medium. Such Fe, consisting of one or 
more octahedral complexes with a coordination environment dominated by O and/or N 
ligands, is the type of Fe expected for mismetallation. 
There is no doubt that apo-Sod2p can and does mismetallate with Fe, but our 
results do not support the view that there is an increased level of Fe mismetallation in 
Δmtm1 cells. Rather, they suggest that in Δmtm1 cells there is a decline in the degree to 
which apo-Sod2p is activated, folded, metallated or matured. Establishing the molecular 
details of this will be a future challenge, but one that is needed to provide further insight 
into the physiological role of this fascinating protein. 
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 CHAPTER IV  
DIRECT DETECTION OF LOW-MOLECULAR-MASS METAL SPECIES IN 
MITOCHONDRIA 
 
Introduction 
There is no doubt that eukaryotic cells contain low-molecular-mass (LMM) non-
proteinaceous transition metals complexes, yet these so-called labile or chelatable metal 
pools are poorly understood in terms of composition, structure and function. Transition 
metal complexes generally exhibit rapid ligand-exchange, making them “moving 
targets” in terms of structural and functional characterization. Low-molecular-mass 
metal complexes (LMMMCs) are thought to participate in metal-ion regulation, 
trafficking, storage and/or signaling in cells. Such cellular processes are often 
dysfunctional in metal-associated diseases. Thus, it is important to characterize such 
complexes, these difficulties notwithstanding.  
The most popular approach to studying LMMMCs is to treat intact cells with 
custom-designed fluorescence-based chelators (also called sensors or probes) that target 
such species when incubated with cells. These probes can penetrate cells and organelles 
without destroying them, a major advantage. However, the sought-after complexes are 
destroyed in the process, since endogenous ligands associated with these complexes 
must dissociate when the probes coordinate the metal. This is a major disadvantage. 
Also, the binding-strength required to chelate a particular pool of LMMMCs is generally 
unknown. Thus, a probe that is too strong might overestimate the size of the pool and a 
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 probe that is too weak might underestimate it. LMMMC pools may also be 
heterogeneous, with multiple LMMMCs contributing. Probes are championed as being 
specific for a particular metal ion, but ideally they should be specific for a particular 
LMM complex. Without this specificity, it would be difficult to decipher the function of 
each component of a pool from the bulk properties of the pool.  
 Since the structures and properties of LMMMCs in cells have not been 
determined, the extent to which they are labile or chelatable also remains uncertain. If 
the ligands exchanged very fast, such complexes would lack a defined shape, raising 
questions of how the cell could recognize and use such complexes in regulation, 
trafficking or signaling. Moreover, the coordination sites of rapidly-exchanging metal 
complexes would allow for fluxional binding and uncontrolled reactions (e.g. the Fenton 
and Haber-Weiss reactions) that could damage the cell. The cell likely reduces the rates 
of ligand-exchange by using tight-binding polydentate ligands. Perhaps this is why 
transition metal ions coordinated solely by waters, erroneously called “free” metal ions, 
are not found in cells.(130)  
Conversely, it is probably inappropriate to view LMMMC as intracellular 
“siderophores” that bind metal ions exceedingly tightly. If LMMMCs in cells are 
involved in trafficking, regulation and signaling, intermediate rates of ligand-exchange 
would seem to be required. These characteristics suggest that it might be possible 
(though perhaps not easy) to detect, isolate and characterize such complexes.  
We are attempting to do exactly this using liquid chromatography (LC) in 
conjunction with an on-line inductively coupled plasma mass spectrometer (LC-ICP-
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 MS). In our system, the eluent from an LC column is split such that a portion is sent to 
the ICP-MS for detection; the rest is sent to a fraction collector. This system will allow 
us to isolate LMMMCs, presuming that they exist and are sufficiently stable to be 
isolated. Such an approach, if successful, would offer a major advantage relative to the 
use of probes since the complexes would not be destroyed. 
 The LC-ICP-MS method should also separates LMMMCs into individual 
complexes such that the vague “pool” concept could be discarded. The disadvantage of 
the LC-based approach is that cells must be disrupted during the preparation of extracts. 
Doing so could alter the pH and redox state of the environment in which the LMMMC 
exists. This might, in turn, induce ligand-exchange or other reactions. The resulting 
artifacts could easily be mistaken for bona fida endogenous LMMMCs. Clearly, both 
approaches will ultimately be required to detect, catalog and fully characterize these 
recalcitrant cellular components.   
In this study we focus on LMMMCs in mitochondria, especially the organelle 
from Saccharomyces cerevisiae. Virtually all mitochondrial proteins are nuclearly 
encoded and many are targeted to the mitochondria by a signal sequence. Proteins 
typically thread through the TIM/TIM protein complexes on the outer and inner 
membranes as unfolded polypeptides. Once in the matrix, the signal sequence is clipped 
and the protein folds. Metalloproteins must be metallated during this process, and so the 
metal ions used for this should be available in the matrix. Given that the IM is very 
“tight”, such metal species would need to enter this space through transporter proteins on 
the IM. Doing so would seem to require small LMMMCs that could pass through such 
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 channels.(60) The situation for metalloproteins in the IMS is probably somewhat 
different. The IMS protein Mia40 binds both Cu and Zn, and may be involved in 
metallating incoming protein.(131) Pores in the OM allow species with Mol. wt < 1 kDa to 
pass unassisted. In this respect cytosolic LMMMCs could serve as metal donors without 
restriction.(60)       
A LMM Mn complex has been detected in soluble mitochondrial extracts 
(Mtm1). When grown on minimal medium and harvested at the end of exponential 
growth phase (OD of 1.0 ± 0.1), a Mn complex with Mol. wt of 2-3 kDa was detected in 
yeast mitochondria.(132) About 1 µM out of 13 µM Mn total in WT mitochondria was 
due to this species, called Mn2-3. When cells were grown with 200 µM MnCl2 in the 
medium, the concentration of Mn2-3 increased to 23 µM. Thus, the concentration of Mn2-
3 in mitochondria is sensitive to the concentration of Mn in the medium. Mn2-3 was the 
only LMM Mn complex detected in the soluble fraction of mitochondria. The 
concentration of Mn2-3 increased (from 1 µM → 22 µM) when Mtm1, an mitochondrial 
IM carrier protein suspected of being involved in activating, maturing or stabilizing apo-
SOD2, was deleted. Since MnSOD2 is the only known Mn-containing protein in 
mitochondria, and since it is imported into the matrix in an apo- form, Mn2-3 likely 
functions as the Mn donor to apo-SOD2.(132)  
LMM Fe complexes in mitochondria have also been detected. Using an assay for 
Fe/S cluster assembly in intact mitochondria, Lutz et al.(133) discovered that 1,10-
phenanthroline (phen), a strong membrane-soluble chelator of FeII ions, inhibits Fe/S 
cluster assembly in intact mitochondria. Similar results were obtained by Amutha et 
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 al.(134) and Pandey et al.(135) who speculated that mitochondria must contain a pool of FeII 
that is used as feedstock for Fe/S cluster assembly. Accordingly, phen was thought to 
penetrate into the matrix and coordinate that pool, making it unavailable for Fe/S cluster 
assembly. Unaware of those results, Holmes-Hampton et al.(121) performed the 
equivalent experiment in which phen was added to intact 57Fe-enriched mitochondria. 
Using Mössbauer spectroscopy, they discovered a pool of nonheme high-spin FeII that 
was selectively chelated by phen, which implied that this pool is used for Fe/S 
biosynthesis. In fermenting mitochondria, the concentration of the pool was ~ 150 µM 
FeII whereas in respiring mitochondria, it was much lower. Since the concentrations of 
respiratory complexes are 3-times higher in respiring mitochondria, Holmes-Hampton et 
al.(121) speculated that this decline was due to an increased rate of Fe/S cluster assembly 
under respiration conditions. This FeII pool is probably that inferred by Amutha and 
Pandey. The associated Mossbauer parameters indicate an FeII species with 5-6 oxygen 
and nitrogen donors but no sulfurs. This HS FeII(O/N)5-6 species appears to be in 
equilibrium with a HS FeIII species and with FeIII oxyhydroxide nanoparticles. The same 
complex may have also been detected by Rauen et al.(136) using rhodamine-based 
fluorescence sensors. These researchers found that the concentration of labile Fe in the 
organelle was ~ 16 µM.(136-138) Consistent with this, a single LMM Fe complex with 
Mol. Wt of ~ 3 kDa was detected in soluble mitochondrial extracts using the LC-ICP-
MS approach.(132) However, further work is required to determine whether this complex 
is the same as that detected by the sensor, by Mössbauer spectroscopy, or by the Fe/S 
cluster assays.   
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 Mitochondria also contain a labile Zn pool that is probably involved in 
metallating various Zn proteins(139), and it may be involved in other functions. 
Mitochondria can accumulate Zn, but this inhibits respiration and causes other 
problem.(140, 141) Cytosolic Zn enters mitochondria through a Ca uniporter.(140) 
Mitochondria from neuronal cells contain Zn that can be mobilized and released when 
the IM is depolarized.(142) Mitochondria in normal prostate epithelial cells accumulate 
high levels of Zn whereas tumorogenic cells do not.(141, 143, 144) Using LC, Winge, Eide 
and coworkers(145) detected a labile Zn pool in the matrix. This pool expanded when they 
increased the concentration of Zn in the medium. Mzm1, a 13.9 kDa soluble matrix 
protein, is involved in maintaining that pool. Zn-specific fluorescence sensors have 
provided further evidence for labile Zn in mitochondria. Palmer and coworkers used 
FRET-based sensors to detect labile Zn in the mitochondria of HeLa cells.(68)  Using 
human carbonic anhydrase II variants, McCranor et. al.(146) detected labile Zn in rat 
mitochondria. Labile Zn was detected in mitochondria from mammalian cells using 
modified GFP fused to calmodulin.(141, 142, 147) Chyan et al.(143) used a synthetic 
fluorescent probe to detect labile Zn in prostate cells. When the medium was spiked with 
50 uM Zn, the fluorescence intensity of the mitos in normal cells increased 2.3 times 
whereas there was no effect on mitochondria in cancer cells. The mitochondria of 
tumerogenic prostate cells do not accumulate labile Zn. Mitochondrial Zn probably 
originates from the Zn-bound to metallothionin in the cytosol. Costello(148) concluded 
that Zn is transferred from donor to acceptor without going through the aquated Zn2+ 
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 state. The IM protein ferrochelatase may use the Zn pool in the matrix to insert into 
porphyrins.   
There is also evidence that mitochondria contain labile Cu. Cobine and Winge 
have reported that > 70% of the Cu in mitochondria is in the form of a non-
proteinaceous species (named CuL) that might serve trafficking and/or metallating 
functions. They refer to the species as being “low molecular weight” but it migrates in 
accordance with a 13 kDa globular protein (149) this is larger than the range of molecular 
masses that we define as low molecular mass (200 – 10,000 Da). Ligand L is fluorescent 
and is present in non-limiting concentrations in the mitochondrial matrix.(150, 151) The 
complex has been detected in both yeast and mouse liver mitochondria. The 
concentration of CuL is sensitive to the concentration of Cu in the medium, increasing 6-
fold in cells grown in medium supplemented with 0.5 mM Cu. Yang(152) used a custom-
designed fluorescent sensor along with synchrotron x-ray fluorescence to detect labile 
Cu in mitochondria. Their data suggest a low-coordinate (linear or trigonal geometry) 
CuI species primarily coordinated by sulfur donors.  Dodani et al.(153)developed a 
fluorescent sensor (Mito-CS1) that selectively binds CuI and targets to the mitochondria 
of HEK293T cells and human fibroblasts. Cells imported extra Cu when supplemented 
with 300 uM CuCl2, and this Cu was sensed by these probes. Cu is thought to be 
imported into the matrix via Pic2, a mitochondrial carrier family protein.(154) Whether 
CuL metallates the Cu-containing proteins in the IMS has been considered but the issue 
remains undecided.(151, 155) 
71 
 
 Considered collectively, these studies indicate the presence and importance of 
LMM transition metal complexes in mitochondria, yet much remains to be done to 
detect, identify and characterize them. In this study, we have used the LC-ICP-MS 
approach to investigate the LMM Mn, Fe, Cu and Zn complexes in mitochondria from 
yeast and to some extent mammalian cells. Our focus has been on detecting such 
species, establishing reproducibility, estimating molecular masses, and quantifying the 
concentrations of such species in the organelle.  
 
Results 
Six independent batches of mitochondria were isolated from WT yeast cells that 
had been grown on minimal medium containing 10 µM Fe (mostly as FeIII citrate), 10 
µM Zn, 2 µM Co, 1 µM Cu (mostly as CuSO4), and 4 nM Mo. We will refer to these 
batches as A, C, D, F, K and P. Four other batches (G, H, I and J) were prepared from 
WT yeast cells grown on the same medium except spiked with a 10-fold increased 
concentration of either Fe, Cu, Zn or Mn. In 8 of these batches, cells were harvested 
during exponential phase (OD600 = 0.8) whereas in 2 of them (A and K), cells were 
harvested during post-exponential phase (OD600 = 1.1 and 1.6, respectively). Three other 
batches of mitochondria were prepared, one each from mouse brain (M), human Jurkat 
cells (N), and mouse liver (O).  
The phosphorus, sulfur, Fe, Zn, Cu, Mn, Co and Mo concentrations of all batches 
were determined by acid digestion and (off-line) ICP-MS (Table 4.1). The approximate 
averaged concentration of phosphorus was highest (26 mM – yeast numbers), followed  
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 Table 4.1. Table of concentrations and %’s of various metals and nonmetals in isolated mitochondria. Yeast of OD 0.8 
consists of 5 independent preps, the other samples are from 1 independent prep of each condition. The concentration of Mo in 
the sample is in pM units. 
 
Sample P          S Mn Fe Co Cu Zn Mo 
Mitochondrial Extract (µM) 
Yeast, OD 0.8 25,500 ± 5,800  5,800 ± 1,200  15 ± 3 440 ± 70 0.075±0.004 52±16  270 ±180 2,000 ± 1,000 
Relative error 23% 21% 20% 16% 5% 31% 66% 50% 
Yeast, OD 1.6 28,600 6,450 20 725 0.125 80 365 1,000 
         
10× Fe yeast 26,300 6,200 12 780 0.081 83 280 2,000 
10× Cu yeast 23,100 6,000 13 410 0.065 140 240 2,000 
10× Zn yeast 27,600 6,000 14 460 0.056 35 480 1,000 
10× Mn yeast 29,400 6,000 25 460 0.049 64 250 2,000 
Jurkat 28,400 7925 18 1,020 0.120 120 220 6,000 
Liver 34,400 8621 16 420 0.080 21 320 8,000 
Brain 32,900 7867 13 380 0.060 25 210 5,000 
         
Flow-Through Solution 
Yeast, OD 0.8 20,700 ± 600 4,900 ± 1100  2 ± 1  100 ± 30  0.060 ± 0.01  26 ± 5 120 ± 40  20 
Yeast, OD 1.6 24,600 5,400 3 150 0.095 34 180 30 
         
10x Fe Mito 21,400 5,300 3 170 0.072 21 120 20 
10x Cu Mito 19,700 5,500 2 100 0.058 120 120 10 
10x Zn Mito 21,200 5,000 2 120 0.049 27 280 20 
10x Mn Mito 23,300 4,900 8 110 0.045 20 120 20 
Jurkat Mito 26,200 6,500 4 110 0.100 22 110 1,000 
Liver Mito 28,400 6,400 3 60 0.072 5 120 1,000 
Brain Mito 26,700 6,300 4 50 0.050 3 110 1,000 
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Table 4.2. Table of percentages of LMM forms of various metals and nonmetals in isolated mitochondria. Yeast of OD 0.8 
consists of 5 independent preps, the other samples are from 1 independent prep of each condition. The concentration of Mo in 
the sample is in pM units. 
 
 
 
 
 
Sample P S Mn Fe Co Cu Zn Mo 
Percentage of mitochondrial extract due to FTS 
Yeast, OD 0.8 83 84 13 24 85 50 44 1 
Yeast, OD 1.6 85 84 15 21 76 43 50 2 
10x Fe Mito 81 86 25 22 89 25 43 1 
10x Cu Mito 85 92 15 25 89 85 51 1 
10x Zn Mito 77 83 14 27 88 77 59 2 
10x Mn Mito 79 81 32 25 92 31 50 1 
Jurkat Mito 92 83 22 11 83 18 49 16 
Liver Mito 83 75 19 15 90 24 39 13 
Brain Mito 81 80 31 14 83 12 52 20 
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 by that of sulfur (6 mM), Fe (440 µM), Zn (270 µM), Cu (52 µM), Mn (15 µM), Co (80 
nM) and Mo (100 pM). Previously reported concentrations are similar; Morales et al.(3) 
obtained Fe, Zn, Cu and Mn concentrations of 770, 290, 50 and 15 µM, respectively. 
The higher [Fe] probably arises because the cells of Morales et al. were grown with 40 
µM FeIII citrate added to the medium and were harvested at an OD600 ~ 1.2. S. cerevisiae 
was recently found to load with Fe when cells are allowed to grow beyond exponential 
phase. Holmes-Hampton et. al.(156) reported concentration of 544, 236, 48, and 12 µM, 
respectively, for cells grown in 10 µM Fe and harvested at OD = 1.2.  
The concentrations of all of these elements were similar in mouse tissues. In the 
human cell sample, P, S, Mn, and Zn concentrations were similar to the other samples 
while Fe, Co and Cu were higher. However, additional batches of these mammalian cells 
are needed before such differences can be considered significant.  
In the current study, increasing Mn, Fe, Cu, and Zn one-by-one in the growth 
medium for yeast cells 10-fold approximately doubled the concentration of the same 
element in the corresponding isolated mitochondria. This shows proportionality between 
the concentration of these metals within the mitochondria and the corresponding 
concentration in the medium. This information would appear to be transferred via the 
cytosol. The regulation of metals in the mitochondria is not so tight as to make the 
mitochondrial concentrations insensitive to environmental changes. 
Also interesting is that the environmentally-induced change in the mitochondrial 
concentration of one metal did not affect the mito concentrations of the other metals. 
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 This shows that the homeostatic systems regulating Fe, Cu, Mn and Zn are, at least at 
this level, independent of each other.  
Isolated mitochondria were then treated with the detergent triton, and then 
centrifuged. The soluble fraction was passed through a 10 kDa cutoff membrane and the 
metal content of the flow-through solution (FTS) was determined (Table 4.1). The 
percentages of mitochondrial metals that were contained in the FTS are given in Table 
4.2. Over 80% of phosphorus, sulfur and Co in mitochondria are LMM species. In 
contrast, only ~20% of mitochondrial Mn, Fe and Cu are LMM species (in the table, the 
% of LMM Cu is listed as 35% but approximately 12% of this is actually Cu-containing 
species that we regard as not being LMM because they have masses > 10 kDa). Slightly 
less than half of mitochondrial Zn is LMM species. This is consistent with Eide et al.(157) 
who reported that > 40% of the Zn in sonicated yeast mitochondrial homogenates was 
soluble (assuming that most of the soluble Zn is also LMM).  
Chromatograms of yeast mito extracts (n=5) exhibited four LMM phosphorus 
species with approximate masses of 1000, 800, 520, and 200 Da (Figure 4.1, Table 4.4). 
We will refer to these species as P1000, P800, P520 and P200. These masses were estimated 
by calibrating the column with various LMM species mention in the previous chapter. 
P520 exhibited the greatest intensity, followed distantly by P1000, P800 and P200. 
The concentrations of these species within mitochondria were as follows. Each peak in 
the chromatogram was fitted using a Gaussian function. Each function was integrated, 
and the area under each peak was normalized to the sum of all of the areas for all peaks 
in the chromatogram. The fractional area associated with a given peak was then 
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 multiplied by the absolute concentration of that element in the FTS, affording the 
absolute concentration of the associated species (Table 4.3). Calculated in this manner, 
the concentration of P520 in isolated mitochondria was approximately 20 mM. ATP and 
ADP, with masses of 507 and 427, respectively, approximately comigrated with P520. 
The P520 peak was broader than other peaks, suggesting that more than one species 
contribute. We conclude that the majority of the P520 peak is due to ATP with perhaps 
with some ADP contributing to the tailing. Since P520 accounts for ~ 90% of the 
chromatographic intensity, we calculate that P520 has a (phosphorus-based) concentration 
of ~ 20 mM. Assuming that this peak represents ATP, the actual concentration of P520 in 
mitochondria is ~ 7 mM.  Yeast mitochondria reportedly contain 7.8 mM ATP.(158)  The 
similarity of these two concentrations not only supports our assignment but also 
indicates that our method of calculating concentrations (at least for phosphorus 
compounds) is relatively accurate.  
P1000, P800 or P200 were not assigned. The estimated mass of P200 is similar to 
pyrophosphate (174 Da) while masses of P1000 and P800 are similar to NADPH (744 
Da).The phosphorus-based concentrations of these three species are 400, 300, and 200 
µM, respectively.  
The phosphorus content of mammalian mitochondria was quite similar to that of 
yeast mitochondria; P520 and the same minor-intensity species were evident. In the 
chromatogram of mitochondria from Jurkat cells, the same minor-intensity peaks were 
present but their intensities were lower than in the others. The chromatograms of liver  
 
77 
 
  
 
Figure 4.1. Phosphorus Chromatograms for LMM Mitochondrial Extracts. Traces A-L 
extracts prepared from yeast mitochondria. A) Trial 1, B) Trial 1 – 5 days aged, C) Trial 
2, D) Trial 3, E) Trial 2 -  5 days aged, F) Trial 4, G) Mitochondria grown on 10x Fe, H) 
G) Mitochondria grown on 10x Cu, I) Mitochondria grown on 10x Zn, J) Mitochondria 
grown on 10x Mn, K) Mitochondria grown to OD600 = 1.6, L) Mitochondria grown to 
OD600 = 1.6 aged for 5 days, M) Mitochondria isolated from Mice brains, N) 
Mitochondria isolated from Human Jurkat cells, O) Mitochondria isolated from Mice 
Livers 
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 Table 4.3. LMMMC’s detected in mitochondrial extracts. Peaks were fit using manual peak fitting to minimize the deviation 
between data and simulation. The appearance of each peak in seen in the far right column with Y = Yeast, M= Mice, 
H=Human Jurkat mitos. 
Peak 
Name 
Peak 
Center 
(mL) 
Peak Width 
(mL) 
Molecular Mass 
(Da) Area (%) 
[Metal]mito 
(µM) 
 
R-value 
(%) 
 
Organism 
P1000 33.4 ± 0.2 0.9 ± 0.1 1000 ± 200 1.7 ± 0.7 400 ± 100 100 Y,M,H 
P800 34.6 ± 0.1 1.3 ± 0.2 800 ± 200 1.5 ± 0.5 300 ± 100 100 Y,M,H 
P520 37.1 ± 0.2 0.7 ± 0.1 520 ± 100 95 ± 18 20000 ± 4000 100 Y,M,H 
P200 42.7 ± 0.2 1.4 ± 0.1 200 ± 50 1.1 ± 0.8 230 ± 140 80 Y,M,H 
S1100 32.8 ± 0.3 1.0 ± 0.1 1100 ± 150 98 ± 1 4900 ± 39 100 Y,M,H 
S780 34.8 ± 0.1 1.4 ± 0.5 780 ± 200 10 ± 9 500 ± 400 60 Y 
Mn2000 30.5 ± 0.2 1.2 ± 0.1 2000 ± 200 45 ~1-2  NA M,H  
Mn1500 30.8 ± 0.2 0.9 ± 0.2 1500 ± 200 4.0 ± 2.0 0.08 ± 0.05 50 Y 
Mn1100 32.6 ± 0.1 0.9 ± 0.1 1100 ± 160 95 ± 7 1.9 ± 0.2 100 Y,M,H 
Fe1500 30.8 ± 0.1 0.8 ± 0.2 1500 ± 300 20 ~22 NA M 
Fe1100 32.7 ± 0.1 1.3 ± 0.2 1100 ± 250 6 ± 2 6 ± 2 80 Y,M 
Fe870 34.1 ± 0.5 0.7 ± 0.1 870 ± 100 11 ± 9 12 ± 9 60 Y,M 
Fe680 35.6 ± 0.4 1.1 ± 0.4 680 ± 130 16 ± 14 20 ± 10 50 Y,M 
Fe575 36.6 ± 0.3 1.4 ± 0.1 575 ± 150 82 ± 17 90 ± 20 100 Y,M,H 
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Table 4.3. (continued.) LMMMC’s detected in mitochondrial extracts. Peaks were fit using manual peak fitting to minimize 
the deviation between data and simulation. The appearance of each peak in seen in the far right column with Y = Yeast, M= 
Mice, H = Human Jurkat mitos. 
Peak 
Name 
Peak Center 
(mL) 
Peak Width 
(mL) 
Molecular Mass 
(Da) Area (%) 
[Metal]mito 
(µM) 
 
R-
value 
(%) 
 
Organism 
Fe200 43.3 ± 0.2 1.2 ± 0.8 200 ± 40 1.7 ± 1.5 2 ± 1 90 Y,M 
Co1200 32.3 ± 0.2 0.9 ± 0.1 1200 ± 180 36 ± 29 0.03 ± 0.02 90 Y,M,H 
Co840 34.3 ± 0.3 1.7 ± 0.6 840 ± 270 29 ± 23 0.02 ± 0.01 90 Y,M,H 
Co620 36.2 ± 0.5 1.6 ± 0.7 620 ± 180 8 ± 4 0.01 ± 0.003 50 Y,M,H 
Co450 38.2 ± 0.5 2.4 ± 0.9 450 ± 200 20 ± 34 0.013 ± 0.22  70 Y,M,H 
Co340 39.8 ± 0.2 1.8 ± 0.4 340 ± 100 9 ± 7 0.006 ± 0.004 90 Y,M,H 
Co300 41.1 ± 0.4 2.0  ± 1.5 300 ± 10 3 ± 2 0.002 ± 0.001 80 Y 
Cu8000 20.4 ± 0.5 3 ± 2 8000 ± 4000 42 ± 38 11 ± 10 40 Y 
Cu5000 23.1 ± 0.1 1.4 ± 0.2 5000 ± 1000 60 ± 26 16 ± 7 90 Y 
Zn1500 30.8 ± 0.2 0.7 ± 0.1 1500 ± 0.2 6 ~7% NA M,H 
Zn1150 32.2 ± 0.2 0.6 ± 0.5 1150 ±100 85 ± 20 110 ± 20 100 Y,M,H 
Zn900 34.1 ± 0.1 1.8 ± 1.3 900 ± 300 5 ± 1 6 ± 1 100 Y 
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 and brain mitochondrial extracts exhibited additional features indicating additional 
phosphorus-containing species.  
 Sulfur-detected chromatograms (Figure 4.2) exhibited two major peaks, 
corresponding to species (S1100 and S780) with masses of 1100 and 780 Da. S1100 
dominated and was observed in all chromatograms; the concentration of this species in 
mitochondria was nearly 5 mM. S780 was present more sporadically. Neither species 
comigrated with glutathione or glutathione disulfide (GSH or GSSG) and no peaks in the 
chromatogram comigrated with GSH or GSSG! This was and is a puzzling result that 
implies the absence of these well-known sulfur-containing species in mitochondria. 
Numerous published studies report millimolar concentrations of GSH in 
mitochondria.(159) Further studies are needed to resolve this discrepancy.  
One peak dominated the Zn-detected chromatograms (Figure 4.3), corresponding 
to a mass of 1100 Da. The so-called Zn1100 species was present at a concentration of 110 
uM (nearly half of the total Zn present in mitos). A minor-intensity peak at 900 Da was 
present at a concentration of ~ 1 uM. Zn1100 is almost certainly the species described by 
Eide, Winge and Cobine, who found that this is a cationic species (suggesting that the 
ligands, on average, are uncharged) and based on their data elutes on a G-25 SEC 
column at a MM of just lower than coenzyme B12.
(145)
 Mitochondria from yeast grown on 
medium containing 10-times more Zn than is normally present in minimal media 
exhibited a 2.5-fold increase in the intensity of the Zn1100 peak. Signal intensities for the 
other peaks were only slightly affected. A higher-mass species Zn2000 was not observed 
in yeast  
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Figure 4.2. Sulfur Chromatograms for LMM Mitochondrial Extracts. Traces A-L 
extracts prepared from yeast mitochondria. A) Trial 1, B) Trial 1 – 5 days aged, C) Trial 
2, D) Trial 3, E) Trial 2 -  5 days aged, F) Trial 4, G) Mitochondria grown on 10x Fe, H) 
G) Mitochondria grown on 10x Cu, I) Mitochondria grown on 10x Zn, J) Mitochondria 
grown on 10x Mn, K) Mitochondria grown to OD600 = 1.6, L) Mitochondria grown to 
OD600 = 1.6 aged for 5 days. M) Mitochondria isolated from Mice brains, N) 
Mitochondria isolated from Human Jurkat cells, O) Mitochondria isolated from Mice 
Livers 
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Figure 4.3. Zinc Chromatograms for LMM Mitochondrial Extracts. Traces A-L extracts 
prepared from yeast mitochondria. A) Trial 1, B) Trial 1 – 5 days aged, C) Trial 2, D) 
Trial 3, E) Trial 2 -  5 days aged, F) Trial 4, G) Mitochondria grown on 10x Fe, H) G) 
Mitochondria grown on 10x Cu, I) Mitochondria grown on 10x Zn, J) Mitochondria 
grown on 10x Mn, K) Mitochondria grown to OD600 = 1.6, L) Mitochondria grown to 
OD600 = 1.6 aged for 5 days. M) Mitochondria isolated from Mice brains, N) 
Mitochondria isolated from Human Jurkat cells, O) Mitochondria isolated from Mice 
Livers 
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 mitochondria chromatograms but was found in mitochondria from mouse samples. In 
Jurkat cells, Zn2000 could be detected but at very low intensity.  
A single Mn species, with a mass of 1100 Da, dominated the chromatograms of 
yeast mitochondrial FTSs. A second minor-intensity species of slightly higher molecular 
mass (Mn1500) was evident in some yeast mitochondrial chromatograms (Figure 4.4). 
The mitochondrial FTS from yeast cells grown in media containing 10-times the normal 
concentration of Mn afforded a chromatogram in which the Mn1100 intensity was 4-times 
greater; the intensity of the Mn1500 species was also increased albeit more modestly. The 
concentration of Mn1100 within yeast mitochondria was ca. 2 uM, while that of Mn1500 
was 23-times less. In our previous study of LMM Mn species in yeast mitochondria 
(Park Mtm1), we observed a single LMM Mn species (Mn2-3) estimated to have a 
molecular mass between 2-3 kDa. This is slightly discordant with our current results in 
which the major LMM Mn species has a mass of 1100 Da. Mn2-3 and Mn1100 may be the 
same species (with one set of calibrations in error). Alternatively, subtle differences in 
the growth of the cells or in preparation of mitochondrial FTSs may have resulted in 
different Mn species being present. We have also considered that Mn1500 and Mn2-3 are 
the same species, and that Mn1100 is a different species that is present in higher 
concentrations under particular growth conditions. Further studies are required to resolve 
this issue.  
Both Mn1500 and Mn1100 were present in mitochondrial FTSs from human cells 
and mouse tissues, but the relative intensities differed relative to those in yeast 
mitochondria. In mitochondria from Jurkat cells, the Mn1500 peak accounted for ~95% of  
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Figure 4.4. Manganese Chromatograms for LMM Mitochondrial Extracts. Traces A-L 
extracts prepared from yeast mitochondria. A) Trial 1, B) Trial 1 – 5 days aged, C) Trial 
2, D) Trial 3, E) Trial 2 -  5 days aged, F) Trial 4, G) Mitochondria grown on 10x Fe, H) 
G) Mitochondria grown on 10x Cu, I) Mitochondria grown on 10x Zn, J) Mitochondria 
grown on 10x Mn, K) Mitochondria grown to OD600 = 1.6, L) Mitochondria grown to 
OD600 = 1.6 aged for 5 days. M) Mitochondria isolated from Mice brains, N) 
Mitochondria isolated from Human Jurkat cells, O) Mitochondria isolated from Mice 
Livers 
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 the overall chromatogram with minor contributions from Mn1100. Mitos from mouse 
brain and liver exhibited a more equal distribution between the two peaks, affording 
concentrations of ~1.5 and ~1.5 µM, respectively.  
Yeast mitochondrial TFSs exhibited one major Fe-detectable peaks, but the mass 
associated with it depended upon the growth phase of the cell when they were harvested 
and whether or not the FTS was injected into the LC-ICP-MS system immediately after 
preparing it or 5 days later. Mitochondrial FTSs isolated from cells that were harvested 
during exponential growth phase (at OD600 = 0.8) exhibited an Fe-detected 
chromatogram dominated by a peak from a species (Fe580) corresponding to a mass of 
580 Da. The chromatogram from a mitochondrial FTS isolated from cells grown on 
media containing a 10-fold increase in FeIII citrate exhibited a 1.7-fold increase in the 
intensity of Fe580. Other minor Fe peaks were evident in the spectra, including a low-
intensity peak corresponding to a mass of 1100 Da.  
Fe-detected chromatograms from FTSs isolated from cells harvested during post-
exponential growth phase (at OD600 = 1.6) differed significantly. They also exhibited 
one major Fe peak but it corresponded to a species (Fe1100) with a mass of 1100 Da. The 
Fe580 peak was present, but at low intensity. Surprisingly, when the FTS dominated by 
Fe1100 was left in the refrigerated glove box for 5 days, the resulting chromatogram was 
dominated by the Fe580 peak, with Fe1100 a minor component. Another Fe containing 
species (Fe870) corresponding to a mass of 870 Da was also evident. We hypothesis that 
Fe1100 spontaneously converted into Fe580 via an intermediate Fe870. The only other Fe 
species present gave rise to a very low intensity peak associated with a mass of 200 Da.  
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Figure 4.5. Iron Chromatograms for LMM Mitochondrial Extracts. Traces A-L extracts 
prepared from yeast mitochondria. A) Trial 1, B) Trial 1 – 5 days aged, C) Trial 2, D) 
Trial 3, E) Trial 2 -  5 days aged, F) Trial 4, G) Mitochondria grown on 10x Fe, H) G) 
Mitochondria grown on 10x Cu, I) Mitochondria grown on 10x Zn, J) Mitochondria 
grown on 10x Mn, K) Mitochondria grown to OD600 = 1.6, L) Mitochondria grown to 
OD600 = 1.6 aged for 5 days. M) Mitochondria isolated from Mice brains, N) 
Mitochondria isolated from Human Jurkat cells, O) Mitochondria isolated from Mice 
Livers 
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 Since hexaqua iron complexes have masses of ca. 160 Da, we assign this peak as 
such. The concentration of Fe200 in our isolated mitochondria samples was 1 – 3 uM 
which we regard as an upper limit of what might be present in mitochondria in cells (one 
half of 1% of the Fe in mitochondria). Alternatively, Fe200 might be an artifact of our 
isolation procedure such that mitochondria in cells might be devoid of hexaqua iron 
complexes.  
Fe chromatograms of FTSs from mitochondria isolated from mammalian cells 
and tissues showed some correspondence to yeast mitochondria but also some additional 
peaks. The chromatogram of FTS from mitochondria isolated from Jurkat cells was 
similar to that of yeast harvested during exponential growth phase, with Fe580 
dominating. That from mouse tissues exhibited three major peaks corresponding to 
masses of 2000, 1200, and 580 Da. The peak at 580 Da probably arises from the same 
species present in yeast mitochondria (Fe580), while that at 2000 Da arises from a species 
(Fe2000) not present in yeast mitochondria. Whether the peak at 1200 Da arises from the 
Fe1100 species in yeast mitochondria is uncertain; the two peaks migrate near to each 
other but they do not seem to co-migrate precisely. The concentrations of these species 
in mammalian mitochondria range from 10-30 µM.   
 Careful analysis of the copper-detected chromatograms revealed deviations in the 
baseline past 30 mL of the elution volume that detracted from the reliability beyond that 
volume (Figure 4.6). As a result, we decided not to analyze that region and have 
presented Cu chromatograms truncated at 30 mL (corresponding to a mass of ~ 2000 Da. 
Further studies will be required to determine whether LMM Cu complexes with masses 
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 < 2000 Da are present in mitochondria. On the other end of these chromatograms, our 
soluble mitochondrial extracts were passed through a 10 kDa cutoff membrane such that 
Cu species with masses > 10,000 Da will not be considered. Since the CuL species 
described by Winge and Cobine has a mass of ~ 13,000 Da, our study was not designed 
to detect this species.(150)  
Within these limitations, the Cu-detected chromatograms of the FTS of 
mitochondria from yeast cells still yielded new insights. The chromatograms were 
dominated by a peak corresponding to a mass of 5000 Da. The concentration of Cu5000 in 
yeast mitochondria was ca. 16 µM. It accounts for ca. 60% of the Cu in the FTS (with 
much of the remainder high-molecular mass Cu species that eluted in the void volume).  
With a mass of 5000 Da, we are uncertain whether Cu5000 is a Cu protein. However, 
there was no major UV (280 nm) peak at 5000 Da, suggesting that it might be non-
proteinaceous.  The Cu5000 peak increased 4-fold in intensity when the Cu concentration 
in the medium was increased 10 fold. Interestingly, the Cu-detected chromatograms of 
the mammalian system did not exhibit peaks in the region between 2000 – ca. 10,000 Da 
(though some Cu species with masses > 10,000 Da were evident). This was similar to the 
results of our previous study of mouse brain LMM extracts, in that no LMM Cu species 
were evident.  
 The Co-detected chromatograms exhibited many peaks, albeit with 
somewhat greater batch-to-batch variability than that observed for other metals (Figure 
4.7). FTSs from yeast mitochondria exhibited peaks between 300 – 1200 Da with the 
dominant peak at 1200 Da. The concentration of the Co1200 species was just 30 nM, a 
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Figure 4.6. Copper Chromatograms for LMM Mitochondrial Extracts. Traces A-L 
extracts prepared from yeast mitochondria. A) Trial 1, B) Trial 1 – 5 days aged, C) Trial 
2, D) Trial 3, E) Trial 2 -  5 days aged, F) Trial 4, G) Mitochondria grown on 10x Fe, H) 
G) Mitochondria grown on 10x Cu, I) Mitochondria grown on 10x Zn, J) Mitochondria 
grown on 10x Mn, K) Mitochondria grown to OD600 = 1.6, L) Mitochondria grown to 
OD600 = 1.6 aged for 5 days. M) Mitochondria isolated from Mice brains, N) 
Mitochondria isolated from Human Jurkat cells, O) Mitochondria isolated from Mice 
Livers 
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Figure 4.7. Cobalt Chromatograms for LMM Mitochondrial Extracts. Traces A-L 
extracts prepared from yeast mitochondria. A) Trial 1, B) Trial 1 – 5 days aged, C) Trial 
2, D) Trial 3, E) Trial 2 -  5 days aged, F) Trial 4, G) Mitochondria grown on 10x Fe, H) 
G) Mitochondria grown on 10x Cu, I) Mitochondria grown on 10x Zn, J) Mitochondria 
grown on 10x Mn, K) Mitochondria grown to OD600 = 1.6, L) Mitochondria grown to 
OD600 = 1.6 aged for 5 days. M) Mitochondria isolated from Mice brains, N) 
Mitochondria isolated from Human Jurkat cells, O) Mitochondria isolated from Mice 
Livers  
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 Factor of 1000 less than many other LMM metal species. Co1200 is probably a member of 
the cobalamin family. Cobalamins have masses in this range, or actually slightly higher. 
Cyanocobalamin (vitamin B12), has a mass of 1355 Da while adenosylcobalamin 
(coenzyme B12) has a mass of 1580 Da. FTS from yeast mitochondria exhibit other 
lower mass species, ranging from 840 to ~ 200 Da, however the batch-to-batch variation 
in these peaks was significant. Peaks in the 200 Da region are probably aqueous Co ions; 
higher mass species from say 340 – 840 Da, are Co complexes, with ligands heavier than 
water, but probably not cobalamins as their masses are too low.  
 Co chromatograms of the mammalian samples were similar to each other, except 
that the intensities of the Co peaks in the Jurkat sample were very low. In comparison to 
the yeast mitochondrial FTSs, those from mammalian cells and tissues exhibited not 
only a peak due to Co1200 but also a peak corresponding to a mass of 1700 Da. The 
associated Co1700 species is probably a member of the cobalamin family. Cobalamins are 
not covalently bound to proteins, and our treatment of mitochondria with the detergent 
Triton could have released some of these centers. Thus, we are uncertain whether these 
chromatograms provide evidence for free cobalamins in intact mitochondria within cells. 
Even if they are artifact of our isolation procedure, they can be used as internal 
molecular mass markers.   
Mitochondria from S. cerevisiae are not known to contain any molybdenum 
enzymes, whereas mammals contain at least two – mARC1/2. These enzymes are found 
on the outer mitochondrial membrane(160) and function to generate nitric oxide from 
nitrites. This is congruent with our study, in which a LMM Mo species was present in 
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 the FTSs of mammalian mitochondria, but not in that from yeast. The mass associated 
with that species is 720 Da. Molybdopterins bind molybdenum in different 
conformations depending on the enzyme sight they originate from ranging from  ~560 – 
980 Da. 
 In summary the work in this chapter provides the foundation for further studies to 
characterize these LMMMCs for both their structure and function. Using a novel LC-
ICP-MS approach labile metals in the mitochondria no longer need to be approached 
from the prospective of being lumped into generalized pools of metals but can be 
discussed in terms of different species or complexes.   
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 CHAPTER V 
LOW MOLECULAR MASS METAL COMPLEXES IN THE MOUSE BRAIN* 
 
Introduction 
Transition metals such as iron, copper, manganese, molybdenum, and cobalt are 
critical components of cells and super-cellular structures like the brain. They tend to be 
redox-active and have excellent catalytic properties that render them common residents 
in the active-sites of enzymes. However, many of those same properties can be 
deleterious to the cell, especially when their ligands are coordinated weakly. Labile FeII 
and CuI complexes in particular can react with H2O2 to generate ˙OH via the Fenton 
reaction.(11, 12) Hydroxyl radicals and other reactive oxygen species (ROS) can damage 
DNA, proteins and membranes. Thus, trafficking newly-imported metal ions from the 
plasma membrane to various apo-protein targets requires chaperones that bind these 
metal ions weakly enough so that they can be transferred from one species to another 
while simultaneously avoiding dangerous side-reactions. Substantial progress has been 
made in understanding metal ion trafficking, but many molecular-level details remain 
unknown.(13) Nowhere is metal ion trafficking more important than in the brain, since 
many neurodegenerative diseases are associated with metal ion accumulation.(161, 162) 
* This chapter is reproduced with permission from “Low Molecular Mass Metal Complexes in Mice Brains”
by Sean P. McCormick, Myrinmoy Chakrabarti, Allison L. Cockrell, Jinkyu Park, Lora S. Lindahl, and Paul  
A. Lindahl 2013, Metallomics, 5, 232- 241, copyright 2013 Royal Chemical Society 
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 The concentration of Fe in the brains of mice fed standard (50 mg Fe per kg) 
chow is ca. 350 μM, with ~50% present as ferritin, ~40% as Fe/S clusters and heme 
centers, and 5%–9% as mononuclear nonheme high-spin (NHHS) FeII and FeIII 
species.(156) Most Fe/S clusters and heme centers reside in mitochondrial respiratory 
complexes where they help provide chemical energy for the brain. Some NHHS FeII ions 
are found in the active sites of enzymes while others may be involved in trafficking. 
NHHS FeII complexes often have weakly-coordinating ligands and engage in Fenton 
chemistry. 
Trafficking of metals involves protein chaperones that bind metal ions in one 
location of the cell and release them in another, e.g. to an apo-protein binding site during 
folding and maturation.(8) Whether trafficking also involves low-molecular-mass (LMM) 
metal complexes is less certain. Such species may exist in aqueous regions of a cell, 
where they might interact with protein chaperones and/or pass through membrane-bound 
transporters. For example, Mrs3p/Mrs4p are membrane-bound mitochondrial proteins 
that transport Fe from the cytosol to the mitochondrial matrix.(163) Although the 
structures of these two proteins are unknown, homologous structures suggest that the 
channels that pass through them are too small to accommodate a protein. This suggests 
that LMM Fe complexes, consisting of the metal ion coordinated by small organic or 
inorganic ligands, and/or by waters, pass through these transporters. 
If LMM metal complexes are involved in trafficking, they should have weakly 
coordinating ligands that can be displaced by strong chelating agents. Pamp et al.(164) 
concluded that labile Fe constitutes 0.2–3% of overall cellular Fe. In human cells 
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 containing 400 μM Fe,(106) this corresponds to a collective labile Fe concentration of 1–
10 μM. Using fluorescence sensors, Petrat et al. found that the concentration of 
chelatable iron in the cytosol of intact hepatocytes was in the same range, namely 5.8 ± 
2.6 μM.(165) According to Rauen et al. about 1% of cellular Fe exists in a pool that is not 
bound to ferritin or other proteins.(136) They estimate that the concentration of chelatable 
Fe in liver mitochondria and in the cytosol is 12 μM(137) and 6 μM,(165) respectively. 
Using chelators of different Fe affinities had no effect on the apparent size of the 
mitochondrial chelatable Fe pool, suggesting that the determined pool concentration (16 
± 2 μM) represents its “true” size. These estimates are substantially less than the 
concentration of NHHS FeII ions present within yeast mitochondria, as quantified by 
Mössbauer spectroscopy.(121) Some Mössbauer-detectable NHHS FeII species may be 
protein-bound and not labile. Differences may also arise from the different organisms 
probed and/or different cellular metabolic growth modes. The Mössbauer-detected 
NHHS FeII ions in yeast are chelated by 1,10-phenantroline (Phen).(121) This attenuates 
Fe/S cluster synthesis,(135) strongly suggesting that these ions serve as feedstock for this 
process. 
The roles of LMM Fe complexes in cells and the brain are unknown, but patterns 
are emerging suggesting involvement in development, aging and neurodegenerative 
diseases. Kaur et al.(166) found an increase in the labile iron pool (LIP) in the brains of 
older mice, suggesting that such ions might be involved in aging. Wypijewska et al.(84) 
found increased LIP in the Substantia nigra region of PD brains. Sohal et al.(167) and 
Magaki et al.(168) reported that 20%–30% of nonheme Fe in the developing mouse brain 
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 was labile. Meguro et al.(169) found that chelatable nonheme FeII and FeIII species were 
distributed heterogeneously throughout the rat brain and that the concentration of these 
species increased with age. Huang et al.(65) reported that psychological stress expands the 
LMM FeIII and FeII pools in particular regions of the brain, as detected by Perl's and 
Turnbull's stains. Nothing is known regarding the particular complexes involved. 
Although not formally a transition metal, Zn plays critical roles in brain 
metabolism.(101) The concentration of Zn in the mouse brain is ca. 320 μM,(156) most of 
which is bound to metalloproteins. Metallothioneins are the primary intracellular Zn-
buffering proteins. Metallothionein III in the brain has a molecular mass (MM) of ca. 7 
kDa and contains 8–11 Zn binding sites.(170) Zn is also found in aggregated amyloid beta 
protein filaments in Alzheimer's Disease (AD), and is associated with amyotrophic 
lateral sclerosis, epilepsy, strokes, depression, and schizophrenia.(171) Protein-based and 
non-protein-based fluorescent probes have been used to image mobile Zn ions in cells 
and tissues.(172, 173) Palmer and coworkers targeted protein-based FRET fluorescence 
sensors to the mitochondria, ER and Golgi of HeLa cells, and estimated the presence of 
such pools at low pM concentrations.(68, 69) The detected concentration of cytosolic Zn 
was also extremely low, namely 80 pM. In contrast, high concentrations of Zn 
(estimated to be mM levels) are found in synaptic vesicles within neurons that use 
glutamate as a neurotransmitter.(174) The synaptic Zn pool has been detected by Zn-
specific fluorescent dyes.(66, 67) These vesicles are located primarily in the cerebral cortex 
and limbic structures. Labile Zn ions enter these vesicles via the membrane-bound 
protein ZnT3 and are released upon synaptic activation.(175) This pool modulates the 
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 overall excitability of the brain, and is involved in signal transduction, memory and 
learning. 
Copper is present in the mouse brain at low concentrations (~5 μM)(156) but it is 
no less important than Fe or Zn. Cu plays essential roles in respiration, oxidative stress 
response, and other enzymatic activities.(176) Cu ions in the brain parenchyma are 
involved in the metabolism of neurotransmitters and myelination.(177) 
Numerous proteins are known to be involved in Cu trafficking. Ctr1 is a 
transporter on the plasma membrane that brings Cu into the cell.(178) Cellular Cu can be 
stored in metallothionein, transported to mitochondria, incorporated into apo-Cu/Zn 
SOD, or transported to the Golgi apparatus for export from the cell.(177) Cu-containing 
ceruloplasmin helps distribute and metabolize Cu, and it may help Fe efflux from the 
brain.(179) Cox17 is an 8.0 kDa protein that transfers cytosolic Cu to mitochondria for 
incorporation into apo-cytochrome c oxidase.(180) CCS1 is a trimer with 9 kDa subunits 
which functions to insert Cu into apo-Cu/Zn SOD.(181, 182) The concentration of CCS1 is 
sensitive to intracellular levels of Cu. Atx1 is an 8.2 kDa copper-binding chaperone that 
transports Cu to the Cu-ATPases in the trans-Golgi network. These proteins, Atp7a and 
Atp7b, deliver Cu for incorporation into proteins.(58) When intracellular Cu 
concentration exceeds some setpoint value, they export Cu from the cell. 
The presence of a labile Cu pool is less certain than that for Fe or Zn. Using 
highly selective ratiometric fluorescent reporters for CuI ions, Domaille et al. found an 
ascorbate-induced increase in the labile CuI pool in HEK 293 T cells.(58) Hirayama et al. 
used a fluorescent sensor to visualize labile CuI pools in mice.(183) 
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 The mouse brain contains ~14 μM Mn, ~400 nM Mo, and ~30 nM Co, 
respectively.(156) Some Mn is incorporated into mitochondrial superoxide dismutase 
which functions to diminish oxidative stress.(181) Mn levels in the brain are elevated in 
patients with AD and Prion disease.(184) Mo is coordinated to the molybdopterin cofactor 
in molybdenum hydroxylases.(43) A deficiency of this cofactor causes seizures and death 
in newborns.(44, 45) Cobalt metabolism in the brain includes lipid biosynthesis and C1 
metabolism.(39, 40) Co is present in coenzyme B12 bound in methionine synthase.
(41) This 
enzyme functions in methionine metabolism, which includes methyl group transfer 
reactions involving choline, folate and S-adenosyl-methionine.(185) 
In this study, we have evaluated the presence of LMM metal complexes in the 
mouse brain. Rather than using specific chelators to identify such species, we have 
detected them using anaerobic liquid chromatography with an on-line ICP-MS following 
the approach of Adams and coworkers who explored the metalloproteome of a 
prokaryote.(186) We report here that the brain contains a limited number of LMM Fe, Co, 
Mn, Mo, Cu and Zn complexes. These complexes were enumerated and characterized in 
terms of concentration and approximate MM. A few species were tentatively assigned. 
 
Results 
The objective of this study was to determine whether the mouse brain contained 
LMM transition metal complexes detectable by LC-ICP-MS. We avoided oxidizing FeII-
containing species due to concern that endogenous ligands might dissociate upon 
oxidation and be replaced by waters, rendering insoluble aqueous FeIII ions that would 
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 adsorb to the column. Once animals were euthanized, all procedures involving samples 
were performed in a refrigerated Ar-atmosphere glove box. In each experiment, isolated 
brains were homogenized and centrifuged, and then supernatants were passed through a 
10 kDa cut-off membrane. Because such complexes could potentially be highly dynamic 
and unstable, samples were prepared for the LC as fast as possible; FTSs were injected 
onto the LC column ca. 3 h after animals were euthanized. Experiments were performed 
13 times to assess reproducibility.  
Elemental concentrations in the FTSs were determined and corrected for dilution, 
affording estimates for the collective concentrations of all the LMM species for these 
elements in the brain. The results were (in μM): Co, 0.06 ± 0.01; Mo, 0.3 ± 0.1; Mn, 0.8 
± 0.1; Cu, 4.2 ± 0.2; Fe, 18 ± 1; Zn, 44 ± 7; S, 1500 ± 70; and P, 11,000 ± 1000 (Table 
5.1). Assuming the total metal concentrations in the brain mentioned in the Introduction 
(except for Co, which was found in the current study to be present in the brain at 88 ± 5 
nM), the percentages of these elements in the brain that passed through the LMM 
membrane were: Co, 66 ± 10; Mo, 67 ± 25; Mn, 6 ± 1, Cu, 84 ± 12; Fe, 5 ± 0.4; Zn, 14 ± 
2; S, 9 ± 2; P, 12 ± 3. Thus, LMM species represent large percentages of total Co, Mo 
and Cu ions in the brain, but small percentages of Mn, Fe, Zn, S and P. For Fe in 
particular, the calculated percentage is comparable to previous chelation-based 
determinations in human cells (see Introduction). 
Given the potential liability of these metal complexes, we evaluated the 
percentage of the metals that eluted from the column, normalized to the amount loaded. 
The averages of three runs were: Mo, 74 ± 12; Mn, 93 ± 4; Fe, 89 ± 7; Co, 93 ± 4; Cu, 
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 84 ± 6; Zn, 92 ± 3; P, 91 ± 3 and S, 92 ± 6, respectively. These values indicate that the 
majority of the metal-containing species in the FLSs eluted from the column. The small  
percentage of each metal that did not elute demonstrates the importance of washing the 
column extensively between runs. 
A total of 13 runs were performed; of these, 11 were analyzed. The two excluded 
runs had peak linewidths 2–3 fold greater than the others (suggesting a problem with the 
column). Thus, our analyses were essentially free of subjective bias. Reproducibility was 
acceptable but there were noticeable variations. P and S chromatograms were the most 
reproducible, in that the same sets of peaks, with similar relative area-ratios, were 
observed in each run. The Ve associated with each peak were not perfectly matched from 
one chromatogram to another, and so small shifts in the volume dimension, 
corresponding to no more than 0.24 mL, were allowed to align S and P peaks to the 
greatest extent possible. The identical alignment offsets were used for the corresponding 
Mo, Mn, Co, Fe, Cu and Zn chromatograms generated in the same run. In this way, the S 
and P chromatograms served as an internal calibration to align the metal-based 
chromatograms. Data sets were not adjusted further. 
We considered that some peaks might arise from degradation products of the 
brain, despite using freshly prepared FTS and working quickly. To examine this, a FTS 
was left for 13 days in a refrigerated box prior to passage through the column. The 
resulting chromatograms, compared to those obtained using fresh FTS, revealed virtually 
no change in relative peak areas and distributions (Figure 5.1). We conclude that our 
samples did not degrade on the time scale of the experiment. 
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 Table 5.1. Concentrations of LMM metal ions in the brain. 
Trace  
Brain LMM Concentrations (µM) 
 P   S    Mn  Fe    Co   Cu   Zn    Mo  
A 10117.78 1577.20 0.910 18.014 0.058 4.564 56.339 0.251 
B 10228.06 1427.36 0.764 17.512 0.051 4.154 38.416 0.168 
C 11644.15 1558.52 0.728 16.653 0.048 4.469 44.594 0.210 
D 10385.55 1490.66 0.692 18.336 0.064 4.092 45.450 0.189 
E 11303.93 1430.73 0.947 18.980 0.058 4.406 38.416 0.293 
F 12312.71 1500.22 0.874 17.763 0.075 4.186 53.250 0.398 
G 11904.76 1573.58 0.692 18.515 0.064 3.903 41.138 0.230 
H 10063.02 1417.55 0.983 18.085 0.051 4.312 39.609 0.147 
I 11363.47 1465.79 0.910 17.405 0.058 4.249 53.127 0.377 
J 11968.04 1436.23 0.837 17.834 0.054 4.123 39.211 0.440 
K 9448.96 1464.04 0.874 16.187 0.061 4.312 40.495 0.335 
L 8771.42 1365.06 0.874 17.369 0.051 4.154 39.303 0.168 
Average 10792.65 1475.58 0.840 17.721 0.058 4.244 44.112 0.267 
Std. Dev 1112.10 66.98 0.099 0.774 0.008 0.181 6.540 0.100 
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Figure 5.1. Chromatograms Obtained  Testing for Sample Degradation. Fresh brain 
extract (black) and 13 Day old (red) refridgerated and stored anearobically were 
analysized as described in the methods section. The traces for P (A), S (B), Cu (C), Zn 
(D), Fe (E), Mn (F) are provided.  
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 We also considered that our results might depend on the FTS buffer employed. 
To examine this, the buffer was switched from Tris to HEPES (both 20 mM at pH 7.4). 
The resulting chromatograms revealed no significant differences (Figure 5.2). 
Remaining run-to-run variations probably arose from animal-to-animal differences. To 
minimize these, mice were euthanized at approximately the same time of day (10 am–12 
noon). Age and gender differences were considered as variational factors, but no 
correlations were obvious. In analyzing datasets, we assumed that any peak observed in 
≥50% of the metal-matched datasets represented a real species in the brain. Peaks 
observed in >25% and <50% of chromatograms were viewed as probably reflecting real 
species. Peaks observed in ≤25% of chromatograms were considered artifacts and were 
not included in downstream analyses. Averages for peaks that were reproducibly present, 
according to these criteria, are summarized in Table 5.2. MMs for each species were 
estimated from Ve and the best-fit linear regression standard-curve line. 
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Figure 5.2. Chromatograms Obtained using HEPES (red) and Tris (black). 
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Table 5.2 Low-molecular-mass metal complexes in the mouse brains. Confidence was 
defined as the number of chromatograms for a given element in which the peak was 
present divided by the total number of chromatograms for that element, multiplied by 
100  
Assigned 
Name 
Peak Center 
(mL) 
Peak Width 
(mL) 
Molecular 
Mass (Da) 
Area 
(%) 
[Metal]Brain 
(µM) 
R-
factor 
(%) 
PHMM V < 18 mL N/A 24-48 kDa 43 ± 14 4641 ± 1510 100 
P2490 29.5 ± 0.3 0.6 ± 0.2 2490 0.8 ± 0.5 86 ± 54 67 
P1950 30.7 ± 0.6 1.0 ± 0.5 1950 1.18 ± 1 127 ± 112 92 
P1240 32.9 ± 0.4 0.7 ± 0.1 1240 7 ± 3 755 ± 323 100 
P1060 33.7 ± 0.2 0.5 ± 0.1 1060 4 ± 3  432 ± 323 41 
P900 34.5 ± 0.3 0.42 ± 0.06 900 3 ± 2 324 ± 216 92 
P630 36.2 ± 0.2 0.5 ± 0.2 630 19 ± 13 2051 ± 1403 83 
P570 36.7 ± 0.2 0.5 ± 0.2 570 15 ± 11 1619 ± 1187 67 
P530 37.1 ± 0.1 0.5 ± 0.1 530 14 ± 10 1510 ± 1079 50 
P490 37.5 ± 0.1 0.5 ± 0.2 490 13 ± 13 1403 ± 1403 58 
       
SHMM V < 18 mL n/a 24-48 kDa 54 ± 10 797 ± 148 100 
S1540 31.84 ± 0.24 0.59 ± 0.10 1540 2.4 ± 1 35 ± 15 100 
S940 34.28 ± 0.38 0.81 ± 0.36 940 1.4 ± 1 21 ± 15 100 
S570 36.70 ± 0.04 0.41 ± 0.06 570 22 ± 13 325 ± 192 92 
S520 37.14 ± 0.07 0.48 ± 0.09 520 17 ± 11 251 ± 162 100 
S370 38.81 ± 0.19 0.67 ± 0.18 370 5 ± 1 74 ± 74 100 
       
CoHMM V < 18 mL n/a 24-48 kDa 8 ± 7 4.64 ± 4 100 
Co1640
 31.54 ± 0.75 0.52 ± 0.06 1640 38 ± 16 22.04 ± 9 100 
Co1380 32.38 ± 0.29 0.75± 0.31 1380 18 ± 8 10.44 ± 4 100 
Co1130 33.38 ± 0.61 0.9± 0.5 1130 15 ± 11 8.7 ± 6.4 100 
Co920 34.38 ± 0.49 0.49± 0.18 920 3 ± 2 1.7 ± 1.2 92 
Co900 34.48 ± 0.33 1.17±1.04 900 1.8 ± 0.8 1.044 ± 0.46 50 
Co630 36.20 ± 0.30 1.25±1.22 630 4.7 ± 4.6 2.726 ± 2.66 75 
Co500 37.40 ± 0.33 1.22±1.29 500 3.2 ± 3 1.856 ± 1.74 75 
Co400 38.45 ± 0.28 0.74 ±0.69 400 2 ± 2 1.16 ± 1.16 58 
Co300 39.72 ± 0.46 0.77 ±0.47 310 1.4 ±0.6 0.812 ± .35 75 
Co210 41.57 ± 0.47 1.10 ±0.93 210 2.0 ± 1.8 1.16 ± 1.04 85 
Coaq 43.88 ± 0.53 1.05 ±1.27 < 200 2.5 ± 2.8 1.45 ± 1.62 50 
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 Table 5.2 (continued) Low-molecular-mass metal complexes in the mouse brains. 
Confidence was defined as the number of chromatograms for a given element in which 
the peak was present divided by the total number of chromatograms for that element, 
multiplied by 100 
Assigned 
Name 
Peak Center 
(mL) 
Peak Width 
(mL) 
Molecular 
Mass (Da) 
Area 
(%) 
[Metal]Brain 
(µM) 
R-
factor 
(%) 
CuHMM V < 19.4 mL n/a 24-48 kDa 60 ±16 2.55 ± 0.68 100 
Cu19390 19.46 ± 0.11 0.82 ±  0.6 19390 23± 12 0.98 ± 0.51 100 
Cu15670 20.5 ± 0.19 0.64 ±  0.13 15670 13 ± 5 0.55 ± 0.21 100 
Cu8650 23.41 ± 0.28 1.03 ± 0.23 8650 2 ± 0.7 0.08 ± 0.03 100 
Cu5680 25.47 ± 0.24 0.63± 0.17 5680 0.5 ± 0.3 0.02 ± 0.01 100 
Cu4230 26.91 ± 0.4 0.71 ± 0.32 4230 0.5 ± 0.2 0.02 ± 0.008 100 
Cu1020 33.86 ± 0.66 0.42 ± 0.19 1020 0.2 ± 0.6 0.01 ± 0.03 92 
Cu370 38.90 ± 0.23 0.60 ± 0.20 370 0.8 ± 0.8 0.03 ± 0.03 100 
       
ZnHMM V < 18 mL n/a 24-48 kDa 86 ± 3 37.94 ± 1.32 100 
Zn19630 19.4 ± 0.4 0.6 ± 0.2 19,630 8.5 ± 4 3.75 ± 1.76 100 
Zn16000 20.4 ± 0.5 0.8 ± 0.4 16,000 5 ± 2 2.21 ± 0.88 92 
Zn1760 31.2 ± 0.5 0.6 ± 0.5 1,760 0.4 ± 0.2 0.18 ± 0.09 42 
Zn400 38.5 ± 0.1 0.4 ± 0.1 400 0.2± 0.1 0.09 ± 0.04 67 
       
FeHMM V < 18 mL n/a 24-48 kDa 98 ± 2 17.37 ± 0.35 100 
Fe3320 28.1 ± 0.4 0.6 ± 0.5 3320 1.4 ± 1.2 0.25 ± 0.21 58 
Fe1720 31.3 ± 0.1 0.6 ± 0.2 1720 0.3 ± 0.2 0.05 ± 0.03 58 
Fe510 37.3 ± 0.3 0.6 ± 0.4 510 0.5 ± 0.3 0.09 ± 0.05 75 
       
MnHMM V < 18 mL n/a 24-48 kDa 77 ± 22 0.65 ± 0.18 100 
Mn3810 27.42 ± 0.24 0.64 ±  0.10 3810 3 ± 1 0.025 ± 0.008 50 
Mn2710 29.08 ± 0.54 0.68 ±  0.24 2710 3± 2.0 0.025 ± 0.017 85 
Mn2040 30.48 ± 0.76 1.38 ± 0.94 2040 11 ± 5 0.09 ± 0.04 58 
Mn1680 31.43  ± 0.3 0.67 ± 0.40 1680 17 ± 9 0.14 ± 0.08 50 
Mn1270 32.81 ± 1.29 1.25 ± 1.08 1270 8 ± 7 0.07 ± 0.06 50 
       
MoHMM V < 18 mL n/a 24-48 kDa 82 ± 12 0.22  ± 0.03 100 
Mo940 34.3 ± 0.5 0.5 ± 0.2 940 2.0 ± 1.6 0.005 ± 0.004 50 
Mo410 38.4 ± 0.6 1.21 ± 0.7 410 5.3 ± 3 0.01 ± 0.008 58 
Mo350 39.1 ± 0.7 0.94 ± 0.4 350 8.6 ± 5 0.02 ± 0.013 67 
Mo240 41.0 ± 0.6 1.6 ± 0.7 240 4 ± 3 0.01 ± 0.008 67 
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 Representative chromatograms of the FLS for each element, along with various 
standard compounds, are shown in Figures. 7.3–10. The P chromatogram (Fig. 5.1) 
exhibited two major regions of peaks. The high-molecular-mass (HMM) region 
corresponds to P-containing compounds with MMs between ca. 13–6 kDa (21–25 mL). 
P-compounds with MMs between 4–0.2 kDa (27–41 mL) are included in the LMM 
region. The intermediate-molecular-mass (IMM) region between 4–6 kDa was 
effectively devoid of peaks. 
The ill-resolved shape of the HMM region suggested that multiple overlapping 
species contributed, and we did not attempt to decompose it. In contrast, the peaks in the 
LMM region were better resolved. These were simulated using the equation  
 2
0
0 maxI
V V
VI I e
ω
− − 
 = +
 
(5.1) 
where ω is the width of the peak and IV, I0, and Imax are the detector responses at 
any volume V, at volume V = 0, and at the volume corresponding to the peak maximum, 
respectively. We integrated the total area under the chromatogram along with the relative 
areas under the individual LMM peaks such that the percentage of the total eluent P due 
to each LMM peak (fcpd-i) could be determined. The concentration of each P-containing 
species represented by the LMM peaks in the brain ([Cpdi]) was calculated using the 
equation  
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Figure 5.3. Phosphorus Chromatograms of Brain FTS and Various Phosphorus-
containing Compounds. (A) Brain FTS; (B) IP6; (C) ATP; (D) ADP; (E) AMP, and (F) 
HPO4
2−. Red lines in Fig. 5.3–5.10 are simulations representing the LMM species listed 
in Table 5.1. The blue line is the overall simulation.  
 
 
 
 
 
 
 
 
 
 
109 
 
  [ ] [ ]i cpd i ftsCpd f P FD−= ⋅ ⋅  (5.2) 
where [P]fts is the concentration of P in the FTS and FD is the fold-dilution used 
to prepare the FTS starting from the intact brain. Similar equations were used to estimate 
the concentrations of all LMM metal and S compounds. Eqn (5.2) assumes that the same 
proportion of each P compound was retained by the column. Maximum and minimum 
concentrations for each compound (Table 5.2) were estimated by assuming that the P 
retained by the column was exclusively either the P species of interest, or other P-
containing species, respectively. 
Eight species were used to simulate the LMM region of the P chromatogram 
(Figure 5.3, Table 5.2). Each was designated by the element followed by a subscript 
indicating its approximate MM. The dominant P peak (P490) comigrated with ADP and 
was assigned as such. Authentic ATP migrated at a slightly smaller Ve and its peak fit in 
the left-side shoulder of P490 as long as the linewidth was increased. Alternatively, the 
peak for ATP and another species could both fit into this shoulder if narrower linewidths 
were assumed. IP6 binds Fe in cells and is thought to be involved in trafficking. 
However, no Fe peaks comigrated with Fe-bound IP6. The remaining P peaks were not 
assigned. Curiously, no peaks comigrated with AMP or orthophosphate. 
Peaks in the representative S chromatogram (Figure 5.4) again segregated into 
HMM, IMM and LMM regions. Again, there were few, if any, S-containing species 
present in the IMM region. 
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Figure 5.4. Sulfur Chromatograms of Brain FTS and Various S-containing Compounds. 
(A) Brain FTS; (B) glutathione, GSH; (C) oxidized glutathione, GSSG. The authentic 
glutathione solution contained some GSSG, while the GSSG solution contained a 
contaminant.   
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 As with P, the S-containing species in the HMM region were poorly resolved and 
only the overall response in this region was determined by simulation. The LMM region 
contained 4 major resolved peaks. The dominant peak (S570) comigrated with GSSG. 
However, its broad linewidth suggested that GSSG and another S species with a similar 
MM contributed. Another peak (S370) nearly comigrated with GSH, and was assigned as 
such. The remaining two species, S1540 and S940 were not assigned. The ratio of peak 
areas for the oxidized and reduced glutathione species was ca. 4:1 GSSG: GSH, 
assuming that one of the two species that contributed to S570 was GSSG. This suggests a 
molar ratio of ca. 2: 1 which is reasonably close to previously reported molar ratios for 
brain samples.(187) 
The Co chromatogram (Figure 5.5) displayed numerous species in the LMM 
region, some HMM peak intensity, and little if any peaks in the IMM region. Of all 
metals detected, Co exhibited the greatest number of LMM species. Cyanocobalamin 
migrated just slightly slower than the dominant Co peak (Co1640), suggesting that Co1640 
might arise from a related complex (e.g. adenosylcobalamin). Aqueous CoII ions 
migrated as multiple species, consistent with rapid ligand/proton exchange reactions. 
The representative Cu chromatogram (Figure 5.6) indicated a HMM region 
containing ca. 5–6 reasonably resolved peaks, with MMs between 19 and 48 kDa. The 
IMM region was devoid of peaks, and the LMM region contained only ca. 2 peaks. 
Although the trace in Figure 7.6 suggests a miniscule amount of aqueous Cu, this feature 
was not reliably present in other traces. 
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Figure 5.5. Cobalt Chromatograms of Brain FTS and Other Co Species. (A) Brain FTS; 
(B) cyanocobalamin; and (C) aqueous Co. The three lowest MM simulations in the 
figure are considered a single species (Coaq) in Table 5.2.   
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Figure 5.6. Copper Chromatograms of Brain FTS and Other Cu Species. (A) Brain FTS 
× 15; (B) brain FTS × 1; (C) CuII(EDTA); and (D) aqueous Cu.   
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 The Zn chromatogram (Figure 5.7) showed a well-resolved HMM region that 
included ca. 5 species. The IMM and LMM regions were virtually devoid of peaks. 
The Fe chromatogram (Figure 5.8) showed a poorly resolved HMM region and 
an IMM region largely devoid of peaks. The LMM region included two significant peaks 
(Fe1720 and Fe510), but these were only observed in 58% and 75% of the chromatograms, 
respectively. In general, there was more variability in the Fe (and Mn) chromatograms 
than in chromatograms from the other metals. In most traces, the ultra LMM region was 
devoid of features (the trace shown in Figure 6.8 shows such a feature, but it was not 
routinely observed).  
The Mn chromatogram (Figure 5.9) included poorly resolved features in the 
HMM region, no features in the IMM region, and a few peaks in the LMM region. 
Mn1270 and the broad feature centered at ca. 28 mL were present in about half of the 
traces. The Mo chromatogram (Figure 5.10) exhibited peaks in the HMM and LMM 
regions, while the IMM region was largely devoid of peaks. The major LMM peak 
(Mo350) comigrated with molybdopterin isolated from xanthine oxidase, suggesting that 
these peaks arise from the same or a closely related species. 
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Figure 5.7  Zinc Chromatograms of Brain FTS and Other Zinc Species. (A) Brain FTS 
×16; (B) brain FTS × 1; (C) ZnII(TPEN); and (D) aqueous Zn.   
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Figure 5.8.  Iron Chromatograms of Brain FTS and Other Iron Species. (A) Brain FTS × 
15; (B) brain FTS × 1; (C) FeII(ATP); and (D) aqueous Fe.   
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Figure 5.9.  Manganese Chromatograms of Brain FTS and Other Mn Species. (A) Brain 
FTS; (B) MnII(EDTA); and (C) aqueous Mn.   
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Figure 5.10. Molybdenum Chromatograms of Brain FTS and Molybdopterin Extract 
From Xanthine Oxidase. (A) Brain FTS; and (B) molybdopterin. The intense peak in B 
with MM ~1.5 kDa was not assigned.   
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 Discussion 
The objective of this study was to determine whether the mouse brain contains 
LMM metal complexes, defined as Mo, Mn, Fe, Co, Cu and Zn complexes possessing 
MMs <10 kDa. Rather than using chelators, our approach was to detect such species 
directly, using ICP-MS to monitor metals eluting from our LMM size-exclusion 
chromatography column. We were careful to avoid oxidation of any redox-active 
complexes, by working in an inert-atmosphere glovebox. We attempted to limit ligand 
substitution reactions by minimizing the time between euthanizing the animals and 
loading the LC column, and by running the column at low temperature. We 
distinguished “real” from artifactual complexes by repeating the experiment 13 times 
and assigning a confidence probability to each species in accordance with the proportion 
of runs in which the species was observed (Table 5.2). Our results were independent of 
buffer used. The vast majority of metal ions loaded on the column did not adhere to it.  
By these criteria, our results indicate that there are 11 Co, 5 Cu, 5 Mn, 4 Mo, 3 
Fe, and 2 Zn LMM complexes in the mouse brain. Of these 30 LMM metal complexes, 
only 2–3 have masses suggesting protein ligation (Cu8650, Cu5680 and perhaps Cu4230). 
The rest have lower MMs which suggest either small peptides as ligands or perhaps 
organic and/or inorganic ligands. 
Except for Cu, all of the metals displayed a significant gap between one edge of 
the HMM region (with MMs > ~20 kDa) and one edge of the LMM region (with MMs 
<4 kDa). The absence of metal complexes between these two regions implies that the 
division into such groups is not arbitrary. Zhuang et al. reported that the shortest (non-
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 alternatively spliced) protein in the mouse genome is 38 residues, which corresponds to 
4.2 kDa.(188) This suggests that the complexes in the HMM region are exclusively 
protein-based and it raises the possibility that the metal complexes in the LMM region 
are either non-proteinaceous or have peptides arising from post-translational truncations. 
Large natural products and siderophores (e.g. actinomycin D, glycosylated antibiotics, 
pyoverdine) have MMs of ca. 1.5 kDa. 
Of the metals examined, Co exhibited the most LMM complexes and perhaps the 
least protein-based species. Cu and Zn displayed the opposite pattern, with numerous 
well-resolved metal-bound proteins and few non-proteinaceous complexes. 
Our results impact the issue of whether cells contain “free” aqueous metal ions. 
They indicate that there are significant concentrations of aqueous Co ions in the brain, 
but do not provide clear evidence of aqueous Cu, Zn, Mn, Mo or Fe ions. ICP-MS is 
quite sensitive, such that the concentration of aqueous metal ion would need to be <10 
nM (ca. 103 ions per cells) to escape detection. In a seminal study published over a 
decade ago, O'Halloran and coworkers argued that there are no “free” or aqueous Cu 
ions in the cell, and that Cu trafficking exclusively involves transferring Cu ions from 
one protein chaperone to the next.(130) Their conclusion was based on ability of the Cu-
loaded chaperone CCS to donate Cu into apo-SOD1 even in the presence of 
bathocuproine sulfate, a strong CuI chelator. Using thermodynamic binding constants, 
they estimated that there is <1 aqueous Cu ion per cell. They rationalized that the 
intracellular milieu must have a large capacity for binding aqueous Cu ions, and that 
aqueous Cu would be dangerous to the cell, due to its tendency to engage in Fenton 
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 chemistry. To the limited extent that our results can detect aqueous Cu (down to ~300 
Cu ions per cell), they support the conclusion that there are no “free”/aqueous Cu ions in 
the mouse brain. 
Similar thermodynamic calculations involving aqueous Zn ions in the cell yield 
concentrations of tens to hundreds of pM. Like Cu, this translates into <1 aqueous Zn ion 
per cell assuming a cell volume of 10−14 L. Aqueous Zn ions also inhibit human receptor 
protein-tyrosine phosphatase in accordance with KI = 21 ± 7 pM,
(189) again suggesting 
very few if any intracellular aqueous Zn ions. Our results suggest the absence of aqueous 
Zn in the mouse brain and provide substantial evidence for protein-based Zn complexes. 
We propose that the Zn species released during the firing of synaptic vesicles have one 
or more non-aqueous ligands. The species released are almost certainly not 
“free”/aqueous Zn. 
Aqueous metal ions rapidly exchange bound waters with the solvent, with rate-
constants that vary in the order NiII < CoII < FeII < MnII < ZnII < CuII.(190) The waters on 
such complexes have average residence times ranging from 10−4–10−10 sec. At moments 
when a coordinated water dissociates, thousands of potential ligands in the cellular 
milieu could interact with the metal at the vacant coordination site. This would promote 
the formation of a new complex. In the likely event that the new ligand would coordinate 
stronger than water, the complex would become less dynamic. Even if no permanent 
complexes formed, the result of this dynamic exchange-reaction would be a population-
distribution of closely related and rapidly interconverting species rather than a single 
entity. Indeed the broad structured peaks obtained from the chromatographic migration 
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 of aqueous metal ions in our study suggest such a population of species. Could such 
dynamical populations serve discrete physiological functions in a cell, or would they be 
deleterious, engaging in uncontrolled side reactions that produce toxic species? We 
suspect that cells could not survive the uncontrollable behavior of most aqueous 
transition metal ions. Moreover, the cell would be unable to regulate such ions since the 
coordinating ligands would not be under genetic control. Chaos would result. 
Accordingly, aqueous metal ions with the fastest water exchange-dynamics 
would seem to be the least likely to exist in a cell, while those with slower exchange-
dynamics might be sufficiently stable. Our detection of aqueous Co ions in FTSs 
supports this possibility, since, of the metals examined, aqueous CoII exchanges water 
ligands slowest. To test this idea further, aqueous NiII ions, which exhibit even slower 
water exchange-dynamics, were added to a FTS prior to passage through the column. A 
single peak with the MM of aqueous NiII was detected. When other aqueous metal ions, 
including Fe, Cu, Zn and Mn were added to the FTS, the only aqueous ion detected in 
the resulting chromatograms was Co (data not shown). Alternatively, or in addition, our 
detection of aqueous Co may arise from the greater sensitivity of Co relative to the other 
metals. 
The fast ligand exchange-dynamics inherent to metal ions are slowed with 
polydentate ligands. Polydentate metal complexes would likely exist as single 
autonomous entities that are not in a dynamic equilibrium with other potential ligands in 
the cell. Slower exchange dynamics would minimize toxic side reactions because they 
would not have dynamically-free sites. Moreover, such ligands would need to be 
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 synthesized and thus regulated by the cell. The shape of such large complexes would 
allow other cellular components (e.g. membrane-bound protein transporters) to 
recognize and distinguish one complex from another. All of these factors favor the 
occurrence in the cell of metal complexes with polydentate ligands. Undoubtedly all of 
the LMM metal complexes characterized in this study are of that type. 
We are particularly interested in metal complexes involved in metal ion 
trafficking – assuming such complexes exist. For such complexes, the coordinating 
polydentate ligands must bind strong enough to avoid the problems mentioned above, 
yet also allow the metal to be transferred to downstream acceptors. In some well-
documented cases, altering the redox state of the metal(191) or the pH(192) of the solution 
are sufficient to labilize the ligands. Binding to a protein or macromolecular complex 
might also labilize the ligands coordinating a metal. One future task will be to identify 
the complexes and the LMM metal-containing proteins that we have detected here.       
Determining the physiological role of each LMM metal complex in the brain that 
we have described in this study will be a challenge that will require multiple 
“orthogonal” approaches. The LC-ICP-MS approach used here is complementary to that 
of treating cells or tissues with custom-designed chelators that react with and sense labile 
metal complexes. The advantage of the chelator-based method is the ability to detect 
labile metal ions in intact live cells. The disadvantages are that such chelators may react 
with multiple species in the cell, and that the process of detection destroys the complexes 
of interest. The advantage of the LC-ICP-MS approach is that individual metal 
complexes can be detected undisturbed (barring potential degradation reactions 
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 occurring during workup). The disadvantage is that the cell itself must be disrupted such 
that critical information regarding cellular compartmentalization is lost. Merging these 
approaches, e.g. using LC-ICP-MS to assess which particular complexes react with 
designer metal sensors, will undoubtedly yield the greatest insight into metal ion 
metabolism in cells and super-cellular structures such as the brain.  
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 CHAPTER VI 
INSIGHTS INTO IRON UPTAKE IN MOUSE PLASMA USING LC-ICP-MS 
 
Introduction 
Iron is a redox-active metal that plays essential roles in mammalian physiology 
and disease.(193) Fe-containing hemoglobin binds and transports O2 to tissues where 
mitochondrial respiratory complexes, packed with Fe-rich cytochromes and Fe/S 
clusters, catalyze O2 reduction. Iron in the brain helps synthesize neurotransmitters and 
myelin that insulates neurons.(194) Iron is critical for the developing hippocampus.(195) 
Young rodent brains experience a growth-associated Fe deficiency due to the inability of 
Fe to be imported fast enough to counterbalance the diluting effect of brain growth. (156, 
196) 
The liver plays a central role in Fe metabolism.(197) Hepatocytes synthesize 
hepcidin, the master regulator of Fe in the body. This peptide hormone controls the 
stability of ferroportin, a membrane-bound protein through which duodenal enterocytes, 
hepatocytes and macrophages export FeII into the blood. Hepatocytes also synthesize 
transferrin, a blood protein that binds FeIII in the plasma. Transferrin is widely 
considered to be the dominant (or even exclusive) Fe component of the plasma, and the 
major (or exclusive) protein that transports plasma Fe into healthy tissues. Transferrin-
bound-iron (TBI) enters cells through the receptor TfR1.(193) Ferritin is a spherically-
shaped Fe-storage protein complex. Liver macrophages contain high levels of ferritin 
(197, 198) which can be exported into the blood. Hepatocytes also synthesize 
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 ceruloplasmin, a blood protein that oxidizes the ferroportin-associated FeII that enters the 
blood. This oxidation to FeIII is required for transferrin binding.  
A significant portion of splenic Fe is found in red-pulp macrophages which 
degrade senescent erythrocytes.(199) The resulting nonheme Fe is released into the blood, 
coordinated to transferrin, and sent to the bone marrow for installation into nascent heme 
groups. As a result, plasma Fe exchanges rapidly. The concentration of Fe in the plasma 
(20 – 50 μM) is largely controlled by ferroportin and hepcidin (193, 198-201) 
Transferrin has a high affinity for aqueous FeIII, yet under normal dietary 
conditions, only_30% of plasma transferrin is Fe bound(201) which implies that the 
concentration of aqueous FeIII in the blood must be very low. Indeed, apo-transferrin 
scavenges free Fe in the plasma. As long as sufficient apo-transferrin is available, 
virtually all 59FeIIICl3 or 59FeIIIcitrate added to plasma will coordinate in minutes.(202-206) 
These results have been interpreted to mean that virtually all Fe in normal plasma is TBI. 
NTBI is thought to play an important (damaging) metabolic role, but only when 
transferrin is fully saturated, e.g. in Fe-overload diseases (201, 207, 208) for which NTBI 
concentrations are high. (209) However, healthy plasma reportedly contains other forms of 
Fe besides transferrin. (210) This contradiction stems from uncertainty or disagreement as 
to the composition, concentration and stability of NTBI. NTBI might be a population of 
Fe complexes, including heme groups, heme:hemopexin complexes, 
hemoglobin:haptoglobin complexes and ferritin (200, 201, 204) and/or Fe coordinated to 
citrate, ascorbate, acetate or albumin.(201, 211-213) 
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 NTBI rapidly enters tissues, especially the live.(202, 205) In heart cell cultures, 
NTBI is imported 300-times faster than TBI.(214) The receptors that import NTBI include 
DMT1, ZIP14, and voltage-dependent Ca channels.(201, 215) The liver and kidney rapidly 
absorb ferritin via TIM2 (216) and Scara5 receptors, respectively. (217) The NTBI importer 
in hepatocytes exhibits an apparent Michaelis-Menten Km of 1.25 μM.
(218) 
The kinetics of Fe import into organs has been evaluated by injecting radioactive 
59Fe into rodents, sacrificing the animals at various times, dissecting organs, and 
measuring how much radioactivity was incorporated. Dallman and Spirito (219) reported 
that the amount of radioactive 59FeCl3 taken up per brain maximized at Postnatal day 18 
(P18). Taylor and Morgan obtained similar results using 59TBI.(200) Both groups 
concluded that the concentration of receptors for Fe import in the brain increased during 
the first 2 weeks of life and then declined. Craven et al. (205) saturated plasma transferrin 
in rodents and then injected 59Fe citrate. 59Fe citrate was absorbed into organs with a t1/2 
< 30 sec, compared to TBI (in controls) which had t1/2 ~50 min. In a related study, Ueda 
et al. (203) blocked transferrin receptors in mice and then injected 59FeCl3 into the blood. 
Within minutes, essentially all of this Fe converted into TBI as monitored by gel 
filtration LC. Malecki et al. (220) injected 59FeCl3 into hypotransferrinemic mice. The rate 
of 59Fe uptake into the brain was nearly 100× faster than with WT mice, confirming that 
NTBI imports faster than TBI. (221, 222) 
The most critical period of mammalian development is from birth to young 
adulthood, yet this is also the most difficult to study using tracers. We developed a Pup 
Swapping method to determine the kinetics of Fe uptake during this period. 56Fe and 
128 
 
 57Fe-enriched pups were swapped at birth, such that each nursed on milk containing the 
opposite isotope. Mathematical models were developed to quantify the rates of Fe import 
from the plasma into major organs. Surprisingly, NTBI rather than TBI was the 
dominant Fe-containing species that incorporated into the organs of healthy non-iron-
overloaded mice at early stages of development. 
      
Results and Discussion 
Initial experiments using the pup swapping protocol resulted in kinetic data of 
iron uptake in mouse organs and mouse plasma over a long time interval (i.e., weeks).  
The concentration of Fe in blood is much higher than the endogenous Fe concentration 
in organs. This high concentration of Fe in blood is primarily located in the red blood 
cells in the form of hemoglobin. In order to understand iron trafficking in blood one 
must look at it in is most transient forms and that would be those found in the plasma 
portion of whole blood.  
As expected, the starting isotope concentration in the plasma, [sFeP], decreased 
with age while that of the enriching isotope, [eFeP], increased. The sum of these 
concentrations, [tFeP], increased slightly with time. The collection of adequate plasma 
volumes in animals under the age of 7 days was difficult due to their small blood 
volumes. In order to estimate [tFeP] for ages 0-7 days it was necessary to use 
extrapoloation of all data collected. 
Our collaborator, Dr. Barlas, using the data developed two models seen in figure 
6.1. One model referred as the one component model made the assumption that a single 
129 
 
 Fe-containing species called FeT was imported into the plasma and that FeT alone was 
deposited into the organs (Figure 6.1, top). At birth, all FeT in the plasma and tissues was 
assumed to be the starting isotope.  eFeT enters the blood at rate Efeed. Both 
eFeT and 
sFeT 
compete for import into organs via a common receptor at the interface with the blood. 
Receptors were treated as Michaelis-Menten enzymes acting on substrates eFeT and 
sFeT. 
Using the solutions to a system of ordinary differential equations we were unable to 
obtain simulations which demonstrated organs becoming enriched at a rate faster than 
that of plasma. 
In order to postulate a system which could explain the enrichment of organs prior 
to plasma a two component model was developed assuming a) Fe enters the plasma 
exclusively as second species called FeNT; b) FeNT in the plasma converts to FeT; and c) 
FeNT and FeT are imported independently into the organs. FeNT could represent a single 
species or many. Using this model and its ODE’s it was possible to simulate the 
observed phenomenon of organ enrichment occurring faster than the plasma as long as 
the rate of import of  FeNT is faster than that of FeT . 
In order to determine the feasibility of a two component plasma model we carried 
out an LC-ICP-MS experiment to determine what iron containing species are present in 
plasma of healthy mice. The liquid chromatogram (LC) exhibited ~6 Fe-associated peaks 
(Figure 5.2). Peaks at > 300, 90, and 55 kDa were assigned to ferritin, transferrin, and 
hemopexin, respectively; the other 3 peaks could not be assigned. The LC-ICP-MS 
experiment demonstrates that numerous Fe-containing species coexist with transferrin in 
healthy WT mouse plasma. 
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Figure 6.1. One Component Model (OCM, top) and Two Component Model (TCM, 
bottom) Describing Fe Import into Mouse Organs. For the OCM, enriching and starting 
isotopes are imported from the gut to the plasma to form species FeT which is imported 
into organs through a receptor. The resulting species FeO can be exported. The TCM is 
similar except that the enriching isotope enters the plasma as a second species FeNT 
which converts to FeT. Both FeNT and FeT can be imported into organs at independent 
rates. 
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Figure 6.2. Chromatogram of Mouse Blood Plasma. (A), transferrin (B), ferritin (C) and 
hemopexin (D). Black lines are the data, red lines are simulations. The blue line is a 
composite simulation including, from left to right, ferritin (6% of the Fe), transferrin 
(17%), unidentified protein 1 (UP1, 6%), hemopexin (69%), and unidentified proteins 
UP2 and UP3 (1% each). UP1 has a molecular mass of 60-80 kDa, while UP2 and UP3 
have masses < 7 kdDa. 
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 The main form of iron known to be present in plasma is that of transferrin bound 
iron (TBI), which in our model would be FeT. However, Fe entering the plasma flows 
through the transporter DMT1 as an FeII species, and then is oxidized by ceruloplasmim 
and coordinated to apo-transferrin. If the FeII species exist in a nontransferrin form 
which we call FeNT, could explain the model. These processes collectively account for 
the FeNT → FeT reaction. Second, NTBI is imported into organs faster than TBI, 
consistent with the more rapid import of FeNT vs. FeT as required by our simulations. 
Third, our analysis requires that plasma contain at least two forms of Fe; by LC, we 
found that plasma contains ca. 6 Fe-containing species only one of which can be TBI. 
Whether any of the other species reflects NTBI is uncertain; the concentration of the 
NTBI in the plasma which is imported rapidly into organs may be below the detection 
limit. 
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 CHAPTER VII 
CONCLUSIONS AND FUTURE WORK 
 
Conclusions 
The major objective of this dissertation was to detect and characterize low-
molecular-mass labile metal complexes (LMMMCs) in eukaryotic cells, organelles and 
in mammalian tissues. Prior studies using metal sensors and chelators have been able to 
detect pools of such species but not distinct complexes. Despite the popularity of these 
methods, this is a serious deficiency. The approach used here was to build a novel liquid 
chromatography system (in a refrigerated inert-atmosphere glove box) in which a portion 
of the eluent flows to an in-line ICP-MS and the remainder flows to a fraction collector 
in the box. Using such a system, labile LMM metal complexes could be detected.  The 
specific function of each species has not been determined, and this remains a challenge 
for the future. However, we anticipate that many of these detected species function in 
metal ion trafficking, metabolism, and/or regulation.  
In collaboration with Dr. Jinkyu Park a study was conducted concerning a 
mitochondrial membrane protein MTM1 that appears to be associated with MnSOD2. 
Previous research suggested that the deletion of Mtm1p resulted in the accumulation of a 
“bioavailable” form of iron which mismetallated apo-SOD2 causing inactivation of the 
protein. Initial biophysical studies performed by Dr. Park failed to detect “bioavailable” 
iron uniquely present in mitochondria isolated from a ∆mtm1 strain. However, large 
amounts of Fe nanoparticles were present. To investigate further, we isolated 
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 mitochondria from the mutant and wild type strains, then solubilized them and subjected 
extracts to both SEC and AEX chromatography using the LC-ICP-MS system. The SEC 
analysis of ∆mtm1 mitochondria showed a Fe species with a mass near that of MnSOD2. 
However, the peak did not co-elute precisely and the relative amounts of the putative 
FeSOD2 relative to that of MnSOD2 was no greater with the mutant strain than with the 
WT strain. Nor was the SOD activity in fractions any lower in the mutant strain than in 
the WT strain when normalized to the amount of SOD2 protein in those fractions. 
Analysis of the AEX chromatography results afforded a similar conclusion, namely that 
apo-SOD2 was not mismetallated to any greater degree in the mutant than in the WT 
strain. Mtm1p does not appear to be directly involved in iron metabolism. Mtm1 most 
likely is an importer of a factor (presumed to be a small molecule) that helps mature apo-
Sod2p, perhaps involving Mn insertion or protein folding. In the absence of Mtm1p, the 
rate of maturation slows and immature Sod2p eventually misfolds. The lack of 
functional MnSod2p increases the concentration of ROS in the matrix, which triggers the 
formation of Fe nanoparticles. The formation of nanoparticles disregulates the import of 
iron in the mitochondria resulting in Fe accumulation.  
A second major result of that study was the detection of a single LMM Mn 
complex that is present in both WT and ∆mtm1 mitochondria. This species was initially 
assigned a mass of 2-3 kDa (current estimates are ~ 1100 Da). In WT mitochondria, the 
concentration of this Mn complex is proportional to the Mn concentration in the growth 
medium, with concentrations ranging from 1 – 10 µM when Mn nutrient concentrations 
of 2 and 200 uM are used. In ∆mtm1 mitochondria, the concentration of the LMM Mn 
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 complex is significantly higher (22 µM). This is the only LMM Mn complex observed in 
yeast mitochondria, and MnSOD2 is the only Mn-containing protein. Since SOD2 enters 
mitochondria unfolded, we hypothesized that the LMM Mn complex donated Mn to apo-
SOD2 during metallation. This is the first description of such a LMM Mn complex in 
mitochondria.  
LMMMCs from WT mitochondria were reinvestigated in Chapter 4, with a 
broader emphasis on all bio-relative metals and a greater emphasis on reproducibility. 
LMM extracts of yeast mitochondria were found to contain 6 Co, 3 Cu, 2 Mn, 5 Fe and 3 
Zn LMM metal complexes and approximately 6 P- and S-containing LLM species. The 
major P-containing peak was broad and approximately comigrated with ATP and ADP. 
The Zn and Mn chromatograms each exhibited a dominate peak in the 1 kDa range. The 
LMM Mn species is probably the same as that observed previously; the exact mass of 
this species will require further study. The concentrations of the Zn and Mn complexes 
in mitochondria were estimated at ~120 and 2 µM, respectively. Numerous LMM cobalt 
species were observed, albeit with low concentrations (10 - 60 nM). The most 
reproducible cobalt peaks comigrated approximately with hydroxycobalmin or 
methylcobalmin. The low intensity of these species was congruent with the absence of 
any known Co-containing proteins in mitochondria. The major Cu species observed in 
WT yeast mitochondria had masses between 5,000 – 10,000 Da which suggests they 
might be Cu-containing peptides. Interestingly, such species were not present in 
mitochondria isolated from human cells or mouse brain or liver. Two major LMM Fe 
species were observed, with relative concentrations that varied with the cell culture 
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 density at the time of harvesting. The major LMM Fe species in mitochondria isolated 
from cells harvested during post-exponential growth mode has a mass of ~1000 da while 
that from cells harvested during exponential growth had a mass of ~ 600 Da. Moreover, 
the 1000 Da Fe complex converted into the 600 Da Fe complex upon incubating samples 
for days in a refrigerated glovebox. Both Fe complexes appear to be present in 
mitochondria.   
The LMM metal complexes in mouse brain were investigated (Chapter 5). In this 
case, 11 Co, 2 Cu, 5 Mn, 4 Mo, 3 Fe and 2 Zn complexes with molecular masses <4 kDa 
were detected. One LMM Mo complex comigrated with the molybdopterin cofactor. 
Most Cu and Zn complexes appeared to be protein-bound with masses ranging from 4–
20 kDa. Co was the only metal for which the “free” or aqueous complex was 
reproducibly observed. Aqueous Co may be sufficiently stable in this environment due 
to its relatively slow water-exchange kinetics. Comparing the peaks observed in the 
isolate mice brain mitochondria and mice brain extracts provides some interesting 
findings.   In the case of phosphorus the major peak is approximately the same MM in in 
each case. In sulfur, however the major mitochondria peak is a minor peak in the brain 
extract chromatograms. For metals like Zn, Co, and Mn the major peak in the 
mitochondria is approximately the same in the brain extract. Copper on the other hand is 
different and it appears that the brain extract has more HMM complexes than the ~5-
8kDa complexes seen in mitochondria. Iron is surprisingly similar with the same 2 major 
peaks in the same approximate MM ranges.  If the concentration of various species in 
the brain extract was corrected for the volume occupied by the mitochondria the 
137 
 
 concentrations are within 10-20% of what we report for isolated brain mitochondria.   In 
conclusion, these are among the first systematic studies of LMM metal complexes in 
yeast cells and mitochondria, and in mouse brain. Further efforts will be required to 
identify these LMM metal complexes unambiguously and to determine their functions.  
The LC-ICP-MS system was also used to examine the Fe containing proteins in 
plasma from mouse blood (Chapter 6). This study investigated the mechanism of iron 
uptake in mice using a stable isotope animal switching method. Mouse organs were 
found to enrich faster than the blood plasma, suggesting the need for two components 
present in the plasma with different rates of exchange. Transferrin is the major protein in 
plasma which transports iron to organs and is thought to be the sole means of transport. 
Chromatograms exhibited ~6 Fe-associated peaks three of which were assigned to 
ferritin, transferrin, and hemopexin. The other 3 peaks could not be assigned. The LC-
ICP-MS experiment demonstrated that numerous Fe-containing species coexist with 
transferrin in healthy WT mouse plasma and thus supports the main conclusion of the 
study.  
 
Future Work 
The studies of this dissertation lay the ground work for further investigations 
regarding the structure and function of LMMMCs. The ability to structurally 
characterize these complexes is primarily limited by the quantity of material available 
for analysis. These LMMMCs are typically present in cells and organelles at low 
micromolar concentrations. Since only a few hundred microliters of solution are loaded 
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 onto the columns, very low molar quantities are available for downstream analysis. 
Thus, multiple runs must be performed, with common peak-containing fractions binned. 
Further work is required to determine appropriate methods for the pre and post 
chromatography sample concentrating without disrupting the structure of the complexes.  
Common methods used by protein chemists involve the use of ultrafiltration membranes, 
lyophilization, or RP prep cartridges.  Ultrafiltration of LMMMC is problematic due to 
limited membrane sizes available. Lyophilization and RP methods both are effective but 
studies are need to identify and minimize ligand exchange processes. A second option to 
investigate would be the use of solid phase extraction techniques which use different 
solvents or stationary phase and could be optimized to the system of interest. 
Increasing the purity of metal complexes is another means by which further 
characterizations might be forthcoming. Adding a second LC column (e.g. AEX after 
SEC) would undoubtedly help increase the purity of these complexes. In previous 
studies, peaks were present with similar masses have been resolved when a second 
dimension such as AEX or hydrophilic interaction liquid chromatography (HILIC) was 
applied.   
Once a species is isolated in a concentrated and pure form, electrospray 
ionization ion mobility mass spectrometry (ESI-IM-MS) would be the method of choice 
to gain information on both the mass and collisional cross section of the complex. Once 
the mass is known structural information can be gained using NMR spectroscopy. The 
major issue with NMR of LMMMCs comes with paramagnetic metal centers. 
Paramagnetic metal centers cause line broadening which makes NMR features difficult 
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 to detect. To alleviate this a background spectra could be acquired and then a chelator 
could be added causing release of the apo-ligand which could then be detected when the 
background spectra are subtracted.  These techniques along with the standard 
biophysical techniques done in the Lindahl lab will provide vital structural information. 
Establishing the function of LMMMCs will require a different type of 
investigation. Here, differences in the concentration of such species due to genetic 
changes in the organism will be a viable approach. For example, the disappearance of a 
LMM Fe complex in mitochondria isolated from a strain of yeast that lacks the 
mitochondrial Fe transporters Mrs3/4 would identify the LMM Fe complex as being 
imported by Mrs3/4. Similar inferences could be made by examining many genetic 
mutant strains and observing the effect on LMM metal complexes. 
The field of metal ion trafficking and homeostasis is still in its infancy but is 
constantly developing as more information on metal transporters, metalloproteins, and 
metallochaperones become available.  A void remains when it comes to understanding 
the structure and function of LMMMCS. The novel LC-ICP-MS system and the 
approach pioneered in this dissertation will hopefully provide a viable means of filling 
that void such that it will play an equally important role along with metal sensor and 
probe studies in revealing the structure and function of these intriguing metal complexes.  
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